Edgewell Personal Care (EPC) 10-Q 7 Aug 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jun. 30, 2018	Jul. 31, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Central Index Key	1,096,752
Current Fiscal Year End Date	--09-30
Entity Filer Category	Large Accelerated Filer
Trading Symbol	EPC
Document Type	10-Q
Document Period End Date	Jun. 30, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		54,040,386

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Net sales	$ 620.6	$ 637.5	$ 1,697	$ 1,733.5
Cost of products sold	317.9	315.4	891.9	873.8
Gross profit	302.7	322.1	805.1	859.7
Selling, general and administrative expense	100.7	97.5	301.4	295.2
Advertising and sales promotion expense	105.3	114.2	229.9	247.3
Research and development expense	14.9	16.4	46.5	50.2
Impairment charge	24.4	0	24.4	0
Restructuring charges	15.4	12.5	19.1	24.9
Sale of Playtex gloves	0.6	0	(15.3)	0
Interest expense associated with debt	16.5	17.6	52.5	52.3
Other expense (income), net	3.5	(1.6)	6.3	(10.1)
Earnings before income taxes	21.4	65.5	140.3	199.9
Income tax provision	9.3	10.6	56.4	45.8
Net earnings	$ 12.1	$ 54.9	$ 83.9	$ 154.1
Basic net earnings per share (in usd per share)	$ 0.23	$ 0.96	$ 1.54	$ 2.68
Diluted net earnings per share (in usd per share)	$ 0.22	$ 0.95	$ 1.54	$ 2.67
Condensed Consolidated Statements of Comprehensive (Loss) Income
Net earnings	$ 12.1	$ 54.9	$ 83.9	$ 154.1
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	(36.3)	43.8	(10.4)	15.1
Pension and postretirement activity, net of tax	1.9	(1.4)	2.6	3.1
Deferred (loss) gain on hedging activity, net of tax	4.4	(1.8)	2.9	2.7
Total other comprehensive income (loss), net of tax	(30)	40.6	(4.9)	20.9
Total comprehensive income	$ (17.9)	$ 95.5	$ 79	$ 175

Condensed Consolidated Stateme3

Condensed Consolidated Statements of Earnings and Comprehensive (Loss) Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Pension and postretirement activity, tax	$ 0.9	$ (0.6)	$ 1.1	$ 1.7
Deferred (loss) gain on hedging activity, tax	$ (2)	$ 0.8	$ (1.3)	$ (1.5)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2018	Sep. 30, 2017
Current assets
Cash and cash equivalents	$ 218.5	$ 502.9
Trade receivables, less allowance for doubtful accounts	225.6	224.1
Inventories	341.4	333.5
Other current assets	135.3	125.7
Total current assets	920.8	1,186.2
Property, plant and equipment, net	427.5	453.4
Goodwill	1,450.7	1,445.9
Other intangible assets, net	1,104.2	1,071.7
Other assets	33.4	31.6
Total assets	3,936.6	4,188.8
Current liabilities
Current maturities of long-term debt	184.9	0
Notes payable	20.9	19.4
Accounts payable	233.9	223.6
Other current liabilities	297	281.4
Total current liabilities	736.7	524.4
Long-term debt	1,096.5	1,525.4
Deferred income tax liabilities	151	181.8
Other liabilities	234.5	215.5
Total liabilities	2,218.7	2,447.1
Shareholders' equity
Preferred shares	0	0
Common shares	0.7	0.7
Additional paid-in capital	1,629.4	1,623.4
Retained earnings	1,046.5	952.9
Common shares in treasury at cost	(822.4)	(703.9)
Accumulated other comprehensive loss	(136.3)	(131.4)
Total shareholders' equity	1,717.9	1,741.7
Total liabilities and shareholders' equity	$ 3,936.6	$ 4,188.8

Condensed Consolidated Balance5

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2018	Sep. 30, 2017
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 8.1	$ 4.3
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	54,001,408	56,017,537
Treasury shares (in shares)	11,250,581	9,234,452

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash Flow from Operating Activities
Net earnings	$ 83.9	$ 154.1
Non-cash restructuring costs	0	6.4
Impairment charge	24.4	0
Depreciation and amortization	73.4	70.3
Share-based compensation expense	14	16.6
(Gain) / loss on sale of assets	(13)	3.9
Deferred compensation payments	(15.4)	(27.6)
Deferred income taxes	(22.9)	(3)
Other, net	(4.1)	(13.1)
Changes in operating assets and liabilities	53	(72.6)
Net cash from operating activities	193.3	135
Cash Flow from Investing Activities
Capital expenditures	(41.8)	(45.4)
Acquisitions, net of cash acquired	(90.2)	(34)
Playtex gloves sale	19	0
Proceeds from sale of assets	4.7	5.9
Net cash used by investing activities	(108.3)	(73.5)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	477	181
Cash payments on debt with original maturities greater than 90 days	(722)	(423)
Net (decrease) increase in debt with original maturities of 90 days or less	0.2	0.1
Common shares purchased	(124.4)	(94.6)
Employee shares withheld for taxes	(2.2)	(15.6)
Excess tax benefits from share-based payments	0	1.9
Net cash used by financing activities	(371.4)	(350.2)
Effect of exchange rate changes on cash	2	4.7
Net increase (decrease) in cash and cash equivalents	(284.4)	(284)
Cash and cash equivalents, beginning of period	502.9	738.9
Cash and cash equivalents, end of period	$ 218.5	$ 454.9

Background and Basis of Present

Background and Basis of Presentation	9 Months Ended
	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Background Edgewell Personal Care Company, and its subsidiaries (collectively, "Edgewell" or the "Company"), is one of the world's largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. Edgewell has a portfolio of over 25 brands and a global footprint in more than 50 countries. The Company conducts its business in the following four segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. Our wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Bulldog® and Jack Black® men's skin care products, Wet Ones® wipes and Playtex® household gloves until the sale of the gloves business in October 2017. Refer to Note 2 for additional details regarding the acquisition of Jack Black, L.L.C. ("Jack Black") and Note 3 for additional details on the sale of the Playtex household gloves business. • Feminine Care includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree® and o.b.® brands. • All Other includes infant care products, such as bottles, cups and pacifiers, sold under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems. Basis of Presentation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP"), under the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 20, 2017. Acquisition of Jack Black. On March 1, 2018, the Company completed the acquisition of Jack Black, a luxury men's skincare products company based in the United States. The results of Jack Black for the post-acquisition period are included within the Company's results since the acquisition date. For more information on the acquisition, see Note 2 of Notes to Condensed Consolidated Financial Statements. Recently Adopted Accounting Pronouncements. In August 2014, the Financial Accounting Standards Board ("FASB") issued a new Accounting Standards Update ("ASU") which requires management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date that the financial statements are issued. This evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. The adoption of this guidance as of October 1, 2017 did not have an impact on the Company's financial statements or the related disclosures. In July 2015, the FASB issued a new ASU which aligns the measurement of inventory under GAAP more closely with International Financial Reporting Standards. Under the new guidance, an entity that measures inventory using FIFO or average cost should measure inventory at the lower of cost or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The adoption of this guidance on a prospective basis as of October 1, 201 7 did not have a material impact on the Company's financial statements or the related disclosures. In March 2016, the FASB issued an ASU which simplifies several aspects of the accounting for share-based payment transactions, including requiring excess tax benefits and tax deficiencies to be recognized as income tax benefits or expenses in the consolidated statement of earnings. The standard requires cash flows from excess tax benefits and deficiencies, previously classified as a financing activity, to be classified as an operating activity in the consolidated statement of cash flows. The Company adopted these provisions of the guidance prospectively in the first nine months of fiscal 2018. As a result, the Company recognized tax deficiencies of $0.7 through income taxes during the first nine months of fiscal 2018 rather than additional paid-in capital. The tax deficiencies were recorded as an operating activity in the Condensed Consolidated Statement of Cash Flows during the first nine months of fiscal 2018. Also, as part of the adoption, a $9.7 adjustment was recorded to increase retained earnings and deferred tax assets to recognize the cumulative amount of previously unrecognized excess tax benefits as of October 1, 2017. Additionally, the ASU requires the presentation of employee taxes paid when an employer withholds shares for tax withholding purposes to be presented as a financing activity in the statement of cash flows as opposed to as an operating activity. This aspect of the new guidance was required to be adopted retrospectively. As such, $15.6 of cash outflows for tax withholding payments were reclassified from an operating activity to a financing activity in the Condensed Consolidated Statement of Cash Flows for the first nine months of fiscal 2017. Finally, under the ASU, the Company elected to record forfeitures as they occur. This election did not have a material impact on the Company's financial statements. In January 2017, the FASB issued new guidance which simplifies the subsequent measurement of goodwill by eliminating step 2 from the goodwill impairment test. Under existing guidance, an entity performs procedures to determine the fair value at the impairment testing date of its assets and liabilities following the same procedures required when determining the fair value of assets acquired and liabilities assumed in a business combination. The amended guidance requires an entity to perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and recognize an impairment charge to the extent the carrying amount exceeds the fair value and does not exceed the total amount of goodwill allocated to the reporting unit. The Company elected to adopt this standard in the third quarter of fiscal 2018 in conjunction with the Company's interim test for goodwill impairment. Refer to Note 7 for discussion on the interim impairment test for goodwill and intangible assets. In March 2018, the FASB issued an ASU which amends the accounting standards codification to reflect the guidance related to the enactment of the Tax Cuts and Jobs Act (the "Tax Act") issued in the SEC Staff Accounting Bulletin No. 118. The Company adopted this standard in the second quarter of fiscal 2018. Refer to Note 5 for disclosures related to the Tax Act. Recently Issued Accounting Pronouncements. In May 2014, the FASB issued an ASU which provides a single comprehensive revenue recognition model for all contracts with customers to improve comparability within industries, across industries and across capital markets. During 2016, the FASB issued three ASUs clarifying the revenue recognition implementation guidance on various topics included within the original ASU. The new guidance will be effective for the Company beginning October 1, 2018, with the option of using either a full retrospective or modified retrospective method. During fiscal 2017, the Company established a cross-functional implementation team, including representatives from all of its businesses globally, to analyze the current processes in place for the recognition of revenue and identify potential differences that would result from application of the new guidance. This initial assessment includes analysis of significant types of arrangements, processes and systems, and reviews of representative contracts. Additionally, the Company has begun reviewing the enhanced disclosure requirements under the new standard. Revenues are primarily generated from the sale of finished products to customers. Those sales predominantly contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. While the assessment is not complete, the timing of revenue recognition is not expected to be materially impacted by the new standard. The Company will adopt the revenue standard using the modified retrospective method in the first quarter of fiscal 2019. In August 2016, the FASB issued an ASU intended to address diversity in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments provide guidance on specific cash flow issues, including debt prepayment or debt extinguishment costs, the sale of accounts receivable, contingent consideration payments on business combinations, proceeds from the settlement of insurance claims and distributions received from equity method investees, among others. The update will be effective for the Company beginning October 1, 2018, with early adoption permitted. The Company noted that the adoption of the standard will reclassify certain operating cash inflows associated with the $150 uncommitted master accounts receivable purchase agreement entered into with The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser on September 15, 2017 (the “Accounts Receivable Facility”) to investing cash inflows in the Condensed Consolidated Statement of Cash Flows by an amount yet to be determined. In February 2018, the FASB issued an ASU which addresses the recently enacted Tax Act. Specifically, the guidance allows the Company to elect to reclassify any "stranded tax" created as a result of the Tax Act from Accumulated Other Comprehensive Loss to Retained Earnings. The new guidance will be effective for the Company beginning October 1, 2018, with early adoption permitted. The Company plans to adopt this standard in the fourth quarter of fiscal 2018. The Company is still assessing the effect of the standard on its consolidated financial statements and disclosures but does not expect the impact to be material. Refer to Note 5 for further disclosures regarding the Tax Act. In June 2018, the FASB issued an ASU which simplifies the treatment of share-based payment transactions used in acquiring goods and services from non employees. The amendments note that measurement of share-based payments used to acquire goods or services should be valued at the grant-date fair value. The grant date is defined as the date at which the grantor and grantee reach a mutual understanding of the terms and conditions of the award. Finally, any awards containing a performance condition should be valued considering the probability of satisfying the necessary performance conditions consistent with employee share-based awards. The update will be effective for the Company beginning October 1, 2019, with early adoption permitted. The Company is in the process of evaluating the impact the guidance will have on its financial statements but does not expect the impact to be material.

Acquisition

Acquisition	9 Months Ended
	Jun. 30, 2018
Business Combinations [Abstract]
Acquisition	Acquisition Jack Black, L.L.C. On March 1, 2018 , the Company completed the acquisition of Jack Black, a men's luxury skincare products company based in the U.S., for $90.2 , net of cash acquired. The acquisition creates opportunities to expand Edgewell's personal care portfolio into a growing global category where it can leverage its international geographic footprint. The acquisition was financed through available operating cash. The Company has recognized the assets and liabilities of Jack Black based on preliminary estimates of their acquisition date fair values. The determination of the fair values of the acquired assets and assumed liabilities, including goodwill and other intangible assets, requires significant judgment. The Company is in the process of finalizing the analysis of its deferred tax positions; as such, this valuation analysis was not complete as of June 30, 2018. The Company will complete the final fair value determination during the fourth quarter of fiscal 2018. As of June 30, 2018, the opening balance sheet for Jack Black included net assets acquired of $93.9 and consisted of working capital and other net assets of $11.9 (including cash of $3.7 ), other intangible assets of $47.7 and goodwill of $34.3 , representing the value of expansion into new markets. Goodwill is expected to be deductible for tax purposes. The intangible assets acquired consisted primarily of the Jack Black trade name, customer relationships and product formulations with a weighted average useful life of 16.6 years. All assets are included in the Company's Sun and Skin Care segment. Acquisition and integration costs related to Jack Black totaling $0.5 and $3.1 in the third quarter and nine months ending June 30, 2018, respectively, were included in Selling, general and administrative expense. Additionally, acquisition and integration costs of $1.8 were included in Cost of products sold in the third quarter of fiscal 2018.

Divestiture

Divestiture	9 Months Ended
	Jun. 30, 2018
Discontinued Operations and Disposal Groups [Abstract]
Divestiture	Divestiture The Company completed the sale of its Playtex gloves business to a household products company for $19.0 on October 26, 2017. The sale allows the Company to better focus and utilize its resources on its other product lines. Total assets sold were approximately $3.7 , resulting in a pre-tax gain on sale of $15.3 .

Restructuring Charges

Restructuring Charges	9 Months Ended
	Jun. 30, 2018
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges Project Fuel In February 2018, the Company announced Project Fuel, an enterprise-wide transformational initiative that is designed to address all aspects of the Company's business and cost structure. The project will incorporate the Company's Zero Based Spending and global productivity initiatives, and will include a new global restructuring initiative. Initial costs for Project Fuel relate to efforts to fully define the scope and reach of the project. In addition, the Company has incurred severance costs related to the reduction of overhead at some of the Company’s manufacturing facilities. While the Company is incurring costs for Project Fuel in fiscal 2018, the majority of costs and savings under Project Fuel are expected to take place during fiscal 2019 through fiscal 2021. In addition to the expected cost savings and improved profitability, Project Fuel is designed to strengthen the Company's challenger culture and reinforce its consumer-centric organizational focus. It is also designed to simplify the organization and streamline ways of working in order to increase competitiveness, speed and agility, and ensure the Company has the skills, capabilities and investments needed to compete in a rapidly changing world. The Company incurred restructuring charges of $15.9 and $19.6 related to Project Fuel in the three and nine months ended June 30, 2018, respectively. Three Months Ended June 30, 2018 Wet Sun and Skin Care Feminine Care All Other Corporate Total Restructuring Severance and related benefit costs $ 1.6 $ 0.2 $ 1.0 $ 0.1 $ — $ 2.9 Consulting, project implementation and management and other exit costs 2.0 0.2 — — 10.8 13.0 Total Restructuring $ 3.6 $ 0.4 $ 1.0 $ 0.1 $ 10.8 $ 15.9 Nine Months Ended June 30, 2018 Wet Sun and Skin Care Feminine Care All Other Corporate Total Restructuring Severance and related benefit costs $ 3.1 $ 0.9 $ 1.1 $ 0.1 $ — $ 5.2 Consulting, project implementation and management and other exit costs 2.0 0.2 — — 12.2 14.4 Total Restructuring $ 5.1 $ 1.1 $ 1.1 $ 0.1 $ 12.2 $ 19.6 In addition, pre-tax Selling, general and administrative expense of $0.5 for the three and nine months ended June 30, 2018, associated with certain information technology enablement expenses related to Project Fuel were included in Consulting, project implementation and management and other exit costs. 2013 Restructuring In November 2012, the Company's Board of Directors (the "Board") authorized an enterprise-wide restructuring plan (the "2013 Restructuring"). The 2013 Restructuring originally included several initiatives focused on reducing costs in general and administrative functions, as well as reducing manufacturing and operating costs associated with the Company's discontinued operations. In January 2014, the Board authorized an expansion of scope of the previously announced 2013 Restructuring, which included rationalization and streamlining of the Edgewell operating facilities and other cost saving initiatives. Restructuring charges have primarily related to plant closure, accelerated depreciation charges, severance and related benefit costs. Costs under this plan totaled $170.1 . Due to an increase in Wet Shave footprint costs and a delay in the transition of manufacturing in the Company's Feminine Care segment from Montreal to Dover, Delaware, some anticipated savings are not expected to be realized until fiscal 2019. The Company does not expect costs related to the 2013 Restructuring program to be material in fiscal 2018 or in future periods. Expenses incurred under the 2013 Restructuring are reflected below, including the estimated impact of allocating such charges to segment results. 2013 Restructuring charges were only allocated to the Company's Wet Shave, Sun and Skin Care and Feminine Care segments for the three and nine months ended June 30, 2017. The Company does not include restructuring costs in the results of its reportable segments. Three Months Ended June 30, 2017 Wet Sun and Skin Care Feminine Care Total 2013 Restructuring Severance and related benefit costs $ 0.4 $ — $ 2.0 $ 2.4 Asset impairment and accelerated depreciation — — 3.6 3.6 Consulting, project implementation and management and other exit costs 2.9 — 3.6 6.5 Total 2013 Restructuring $ 3.3 $ — $ 9.2 $ 12.5 Nine Months Ended June 30, 2017 Wet Sun and Skin Care Feminine Care Total 2013 Restructuring Severance and related benefit costs $ 1.1 $ — $ 4.4 $ 5.5 Asset impairment and accelerated depreciation — — 6.4 6.4 Consulting, project implementation and management and other exit costs 6.8 0.1 6.1 13.0 Total 2013 Restructuring $ 7.9 $ 0.1 $ 16.9 $ 24.9 In addition, pre-tax costs of $0.3 and $0.7 for the three and nine months ended June 30, 2017, respectively, associated with obsolescence charges related to the exit of certain non-core product lines as part of the 2013 Restructuring, were included in Cost of products sold. Restructuring Reserves The following table summarizes Project Fuel and 2013 Restructuring activities and related accruals (excluding certain obsolescence charges related to the 2013 Restructuring): Utilized October 1, 2017 Charge to Other (1) Cash Non-Cash June 30, 2018 Restructuring Severance and termination related costs $ 2.4 $ 5.2 $ — $ (4.6 ) $ — $ 3.0 Other related costs — 14.4 — (7.3 ) — 7.1 Total Restructuring $ 2.4 $ 19.6 $ — $ (11.9 ) $ — $ 10.1 Utilized October 1, 2016 Charge to Other (1) Cash Non-Cash September 30, 2017 Restructuring Severance and termination related costs $ 16.7 $ 6.5 $ (0.3 ) $ (20.5 ) $ — $ 2.4 Asset impairment and accelerated depreciation — 6.9 — — (6.9 ) — Other related costs — 16.2 — (16.2 ) — — Total Restructuring $ 16.7 $ 29.6 $ (0.3 ) $ (36.7 ) $ (6.9 ) $ 2.4 (1) Includes the impact of currency translation.

Income Taxes

Income Taxes	9 Months Ended
	Jun. 30, 2018
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three and nine months ended June 30, 2018, the Company had income tax expense of $9.3 and $56.4 , respectively, on Earnings before income taxes of $21.4 and $140.3 , respectively. The effective tax rate for the three and nine months ended June 30, 2018 was 42.9% and 40.2% , respectively. The difference between the federal statutory rate and the effective rate for the nine months ended June 30, 2018 is primarily due to a $17.4 net transitional charge resulting from the enactment of the Tax Act, as discussed below, and the impact of the goodwill impairment. For the three and nine months ended June 30, 2017, the Company had an income tax expense of $10.6 and $45.8 , respectively, on Earnings before income taxes of $65.5 and $199.9 , respectively. The effective tax rate for the three and nine months ended June 30, 2017 was 16.2% and 22.9% , respectively. The difference between the federal statutory rate and the effective rate for both periods is due to a higher mix of earnings in lower tax rate jurisdictions and was favorably impacted by restructuring charges in higher tax rate jurisdictions. U.S. Tax Reform On December 22, 2017, the U.S. government enacted the Tax Act. This new comprehensive tax legislation reduces the U.S. federal corporate tax rate from 35% to 21% but also limits and/or eliminates certain deductions while creating new taxes on certain foreign sourced earnings. Since the Company has a September 30 fiscal year end, the lower U.S. corporate income tax rate will be phased in, resulting in a blended U.S. statutory federal rate of approximately 24.5% for the fiscal year ending September 30, 2018 and 21% for subsequent fiscal years. The reduction in the U.S. corporate tax rate requires the Company to remeasure its U.S. deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which can be 24.5% or 21% . The Tax Act also imposed a one-time transition tax on historical earnings of certain foreign subsidiaries that were not previously taxed by the U.S. Due to the Company’s fiscal year end, certain tax provisions of the new Tax Act will impact the Company in fiscal 2018 while others will be effective in subsequent years. For the nine months ended June 30, 2018, the estimated impact of the one-time transition tax on foreign earnings was $94.2 , offset by the estimated benefit of remeasurement of U.S. deferred tax assets and liabilities of $76.8 . The net impact of these transitional provisions resulted in a net charge of $17.4 for the year, which was included as a component of income tax expense. The Company has tax loss carryforwards and tax credits, a portion of which are expected be used to partially offset amounts payable over eight years related to the one-time transition tax on foreign earnings. The tax law changes included in the Tax Act are broad and complex. The final impact may differ from the Company's estimates, possibly materially, due to, among other things, changes in interpretation of the Tax Act, legislative action to address questions that arise because of the Tax Act, changes in accounting standards for income taxes or related interpretations in response to the Tax Act, or updates or changes to estimates the Company used to calculate the transition impacts, including impacts from changes to earnings estimates, foreign income tax estimates and foreign exchange rates. The Securities and Exchange Committee ("SEC") has issued rules under Staff Accounting Bulletin 118 that would allow for a measurement period of up to one year after the enactment date of the Tax Act to finalize the recording of the related tax impacts. As of June 30, 2018, amounts recorded for the Tax Act remain provisional for the transition tax, remeasurement of deferred taxes and reassessment of permanently reinvested earnings. On August 1, 2018, proposed Treasury Regulations were issued under Section 965 providing additional guidance and clarification on many of the provisions associated with the one-time transition tax, enacted in connection with the Tax Act. The Company has not yet evaluated these proposed regulations nor the impact they may have on the provisional amounts recorded for the transition tax as of June 30, 2018.

Earnings per Share

Earnings per Share	9 Months Ended
	Jun. 30, 2018
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share is based on the average number of common shares outstanding during the period. Diluted earnings per share is based on the average number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options and restricted share equivalent ("RSE") awards. Following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended June 30, Nine Months Ended June 30, 2018 2017 2018 2017 Basic weighted-average shares outstanding 54.0 57.2 54.5 57.4 Effect of dilutive securities: RSE awards 0.1 0.3 0.1 0.3 Total dilutive securities 0.1 0.3 0.1 0.3 Diluted weighted-average shares outstanding 54.1 57.5 54.6 57.7 For the three and nine months ended June 30, 2018 , the calculation of diluted weighted-average shares outstanding excludes 0.5 of share options because the effect of including these awards was anti-dilutive. For the three and nine months ended June 30, 2018 , the calculation of diluted weighted-average shares outstanding excludes 0.1 of RSE awards because the effect of these awards was anti-dilutive. For the three and nine months ended June 30, 2017, the calculation of diluted weighted-average shares outstanding excludes 0.6 of share options because the effect of including these awards was anti-dilutive.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table sets forth goodwill by segment: Wet Sun and Skin Feminine All Total Balance at October 1, 2017 $ 971.2 $ 195.6 $ 209.5 $ 69.6 $ 1,445.9 Acquisition of Jack Black — 34.3 — — 34.3 Cumulative translation adjustment (2.6 ) (0.3 ) (2.2 ) — (5.1 ) Impairment charge — — — (24.4 ) (24.4 ) Balance at June 30, 2018 $ 968.6 $ 229.6 $ 207.3 $ 45.2 $ 1,450.7 Accumulated goodwill impairment losses totaled $24.4 at June 30, 2018 in the All Other segment. Total amortizable intangible assets were as follows: June 30, 2018 September 30, 2017 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 206.7 $ 23.0 $ 183.7 $ 188.6 $ 16.0 $ 172.6 Technology and patents 79.0 75.7 3.3 77.9 74.4 3.5 Customer related and other 179.7 94.5 85.2 151.5 89.8 61.7 Total amortizable intangible assets $ 465.4 $ 193.2 $ 272.2 $ 418.0 $ 180.2 $ 237.8 Amortization expense was $4.6 and $13.2 for the three and nine months ended June 30, 2018 , respectively, and $4.0 and $12.1 for the three and nine months ended June 30, 2017, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2018 and for fiscal 2019, 2020, 2021, 2022 and 2023 is approximately $4.5 , $17.8 , $17.2 , $16.6 , $16.4 and $16.4 , respectively, and $183.5 thereafter. Amortizable intangible assets include $17.5 of trade names and brands, $1.2 of technology and patents, $0.5 of non-compete agreements, and $28.5 of customer related intangibles from the Jack Black acquisition. See Note 2 of the Notes to Condensed Consolidated Financial Statements for more information on the Jack Black acquisition. The Company had indefinite-lived intangible assets of $832.0 ( $182.2 in Wet Shave, $476.1 in Sun and Skin Care, $29.9 in Feminine Care and $143.8 in All Other) at June 30, 2018 , a decrease of $1.9 from September 30, 2017 related to foreign currency translation rates. Goodwill and intangible assets deemed to have an indefinite life are not amortized, but reviewed annually during the fourth fiscal quarter for impairment of value or when indicators of a potential impairment are present. The Company continuously monitors events which could trigger an interim impairment analysis, such as changing business conditions and environmental factors. The Company experienced a sustained decline in market capitalization during the third quarter of fiscal 2018, leading to the determination that a triggering event had occurred for all reporting units. The Company performed an interim impairment analysis using financial information through June 30, 2018 and forecasts for cash flows developed using the Company's three year strategic plan. The interim impairment analysis was performed in a manner consistent with the annual impairment test using both the market and income approaches and weighting them based on their application to the reporting units. The interim impairment review was performed across all reporting units and indefinite lived intangible assets. The interim impairment analysis required an increase in discount rates across all reporting units to align with market-based assumptions and company specific risks. The analysis indicated that the carrying amount of the goodwill for the Infant Care reporting unit was greater than its fair value. The impairment of the Infant Care reporting unit was calculated as the difference between its fair value, determined in the interim impairment review, and the carrying value. As a result, the Company recorded an impairment charge on the goodwill of the Infant Care reporting unit totaling $24.4 as of June 30, 2018. The valuation of the Infant Care reporting unit decreased compared to the prior year because of the higher discount rates in conjunction with lower forecasted revenue growth rates and earnings margins, resulting in lower projected long-term future cash flows. In addition to the impairment of the Infant Care reporting unit, the fair values of the Skin Care and Feminine Care reporting units were between 104% and 106% of their carrying values, respectively. Key assumptions used in valuing the reporting units include the weighted average cost of capital of 10.2% and 9.7% for Skin Care and Feminine Care, respectively. The long term revenue growth rates applied to the valuation models were 2.00% for Skin Care and 0.50% for Feminine Care. The fair value of the Wet Ones indefinite lived intangible asset was 103% of its carrying value. Key assumptions used in the valuation of the Wet Ones intangible asset were a 9.75% discount rate and a 1.25% long term revenue growth rate. Unfavorable fluctuations in the discount rate or declines in forecasted sales and margins could result in impairment of these reporting units and intangible assets. The Company will continue to evaluate the fair value of goodwill and intangible assets through the fourth quarter of fiscal 2018 for potential impairment. During fiscal 2017, the Company recorded impairment charges of $312.0 and $7.0 on its Playtex and Edge brand names, respectively. The impairment of Playtex and Edge in fiscal 2017 was the result of intense competition in the Feminine Care and Wet Shave segments which resulted in decreased market share. Based on the impairment taken and continued competitive pressure on the Playtex and Edge brands, the intangible assets associated with the brand names were converted to definite-lived assets as of July 1, 2017 and assigned a useful life of 20 years . The conversion of the Playtex and Edge brand names to definite-lived intangible assets increased amortization expense by $1.8 and $5.4 for the three and nine months ended June 30, 2018, respectively.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	9 Months Ended
	Jun. 30, 2018
Supplemental Balance Sheet Information [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information June 30, September 30, Inventories Raw materials and supplies $ 47.0 $ 50.6 Work in process 60.4 60.9 Finished products 234.0 222.0 Total inventories $ 341.4 $ 333.5 Other Current Assets Miscellaneous receivables $ 15.2 $ 16.9 Prepaid expenses 77.4 55.6 Value added tax collectible from customers 26.9 25.2 Income taxes receivable 11.0 24.7 Other 4.8 3.3 Total other current assets $ 135.3 $ 125.7 Property, Plant and Equipment Land $ 19.2 $ 19.3 Buildings 142.4 139.1 Machinery and equipment 960.6 947.4 Capitalized software costs 48.3 42.3 Construction in progress 51.7 49.7 Total gross property 1,222.2 1,197.8 Accumulated depreciation (794.7 ) (744.4 ) Total property, plant and equipment, net $ 427.5 $ 453.4 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 49.4 $ 32.2 Accrued trade allowances 24.7 24.6 Accrued salaries, vacations and incentive compensation 46.6 40.6 Income taxes payable 24.2 18.3 Returns reserve 49.8 53.3 Restructuring reserve 10.1 3.0 Value added tax payable 7.8 5.8 Deferred compensation 4.7 13.8 Other 79.7 89.8 Total other current liabilities $ 297.0 $ 281.4 Other Liabilities Pensions and other retirement benefits $ 97.2 $ 109.4 Deferred compensation 43.0 47.3 Long-term income taxes payable 36.1 — Other non-current liabilities 58.2 58.8 Total other liabilities $ 234.5 $ 215.5

Accounts Receivable Facility

Accounts Receivable Facility	9 Months Ended
	Jun. 30, 2018
Transfers and Servicing [Abstract]
Accounts Receivable Facility	Accounts Receivable Facility On September 15, 2017, the Company entered into a $150 uncommitted master accounts receivable purchase agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser. Transfers under this agreement are accounted for as sales of receivables, resulting in the receivables being de-recognized from the consolidated balance sheet. As of June 30, 2018, the discount rate used to determine the purchase price for the subject receivables is based upon LIBOR plus a margin applicable to the specified obligor. Account receivables sold under this agreement for the three and nine months ended June 30, 2018 were $328.5 and $820.1 , respectively. The trade receivables sold that remained outstanding under this agreement as of June 30, 2018 and September 30, 2017 were $136.9 and $81.7 , respectively. The dilution reserve, which represents the Company's retained interest in sold receivables, was $13.7 and $8.2 as of June 30, 2018 and September 30, 2017, respectively, and was recognized on the Consolidated Balance Sheets as a receivable. The difference between the carrying amount of the trade receivables sold and the sum of the cash received was recorded as a loss on sale of receivables in Other expense (income), net in the Consolidated Statement of Earnings. For the three and nine months ended June 30, 2018, the loss on sale of trade receivables was $0.8 and $1.8 , respectively.

Debt

Debt	9 Months Ended
	Jun. 30, 2018
Debt Disclosure [Abstract]
Debt	Debt The detail of long-term debt was as follows: June 30, September 30, Senior notes, fixed interest rate of 4.7%, due 2021, net (1) $ 598.6 $ 598.3 Senior notes, fixed interest rate of 4.7%, due 2022, net (1) (2) 497.9 497.4 U.S. revolving credit facility due 2020 — 245.0 Term loan, due 2019, net (1) 184.9 184.7 Total long-term debt, including current maturities 1,281.4 1,525.4 Less current portion 184.9 — Total long-term debt $ 1,096.5 $ 1,525.4 (1) At June 30, 2018 , the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.4 , $1.6 and $0.1 , respectively. At September 30, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.7 , $1.9 and $0.3 , respectively. (2) At June 30, 2018 and September 30, 2017, the balance for the senior notes due 2022 is reflected net of discounts of $0.5 and $0.7 , respectively. The Company had outstanding international borrowings, recorded in Notes payable, of $20.9 and $19.4 as of June 30, 2018 and September 30, 2017 , respectively.

Retirement Plans

Retirement Plans	9 Months Ended
	Jun. 30, 2018
Retirement Benefits [Abstract]
Retirement Plans	Retirement Plans The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries, which are included in the information presented below. The plans provide retirement benefits based on years of service and earnings. The Company also sponsors or participates in a number of other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below. The Company's net periodic pension and postretirement benefit (credit) cost for these plans was as follows: Three Months Ended June 30, Nine Months Ended June 30, 2018 2017 2018 2017 Service cost $ 1.5 $ 1.8 $ 4.6 $ 5.5 Interest cost 4.3 3.7 12.9 11.2 Expected return on plan assets (7.9 ) (7.9 ) (23.8 ) (23.8 ) Recognized net actuarial loss 1.1 1.6 3.4 4.6 Settlement loss recognized — — — 0.3 Net periodic benefit (credit) cost $ (1.0 ) $ (0.8 ) $ (2.9 ) $ (2.2 )

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Jun. 30, 2018
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Shareholders' Equity During the nine months ended June 30, 2018 , the Company repurchased 2.1 shares of its common stock for $124.4 , all of which were purchased under the Board authorization from May 2015. In January 2018, the Board approved an authorization to repurchase up to 10.0 shares of the Company's common stock, replacing the previous stock repurchase authorization from May 2015. The Company has 10.0 shares remaining under the January 2018 Board authorization to repurchase its common shares in the future. Future share repurchases, if any, would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs and other factors. During the nine months ended June 30, 2018 , the Company paid $0.1 in cash dividends related to the vesting of RSE awards, which had been declared and accrued during prior fiscal years. The Company has not declared any dividends since the third quarter of fiscal 2015, and does not currently intend to declare dividends in the foreseeable future.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Jun. 30, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The following table presents the changes in accumulated other comprehensive loss ("AOCI"), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2017 $ (29.0 ) $ (101.3 ) $ (1.1 ) $ (131.4 ) OCI before reclassifications (1) (10.4 ) 0.2 1.2 (9.0 ) Reclassifications to earnings — 2.4 1.7 4.1 Balance at June 30, 2018 $ (39.4 ) $ (98.7 ) $ 1.8 $ (136.3 ) Foreign Pension and Hedging Total Balance at October 1, 2016 $ (68.1 ) $ (126.3 ) $ (2.8 ) $ (197.2 ) OCI before reclassifications (1) 15.1 (0.1 ) 4.3 19.3 Reclassifications to earnings — 3.2 (1.6 ) 1.6 Balance at June 30, 2017 $ (53.0 ) $ (123.2 ) $ (0.1 ) $ (176.3 ) (1) OCI is defined as other comprehensive income (loss). The following table presents the reclassifications out of AOCI: For the Three Months Ended For the Nine Months Ended June 30, Affected Line Item in the Condensed Consolidated Statements of Earnings Details of AOCI Components 2018 2017 2018 2017 (Loss) / gain on cash flow hedges Foreign exchange contracts $ (1.0 ) $ 1.1 $ (2.5 ) $ 2.5 Other expense (income), net (1.0 ) 1.1 (2.5 ) 2.5 Total before tax 0.4 (0.4 ) 0.8 (0.9 ) Tax expense (0.6 ) 0.7 (1.7 ) 1.6 Net of tax Amortization of defined benefit pension and postretirement items Actuarial losses (1.1 ) (1.6 ) (3.4 ) (4.6 ) (1) Settlement loss recognized — — — (0.3 ) (1) (1.1 ) (1.6 ) (3.4 ) (4.9 ) Total before tax 0.3 0.6 1.0 1.7 Tax expense (0.8 ) (1.0 ) (2.4 ) (3.2 ) Net of tax Total reclassifications for the period $ (1.4 ) $ (0.3 ) $ (4.1 ) $ (1.6 ) Net of tax (1) These AOCI components are included in the computation of net periodic benefit cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Risk

Financial Instruments and Risk Management	9 Months Ended
	Jun. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management At times, the Company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency risk. The Company has master netting agreements with all of its counterparties that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties and its counterparty netting arrangements. The section below outlines the types of derivatives that existed at June 30, 2018 and September 30, 2017 , as well as the Company's objectives and strategies for holding derivative instruments. Foreign Currency Risk A significant share of the Company's sales is tied to currencies other than the U.S. dollar, the Company's reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact on reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the Euro, the Japanese Yen, the British Pound, the Canadian Dollar, the Czech Koruna and the Australian Dollar. Additionally, the Company's foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary's local currency at the end of each period. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary's local currency results in an exchange gain or loss recorded in Other expense (income), net. The primary currency to which the Company's foreign subsidiaries are exposed is the U.S. dollar. Cash Flow Hedges At June 30, 2018 , the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective for accounting purposes in offsetting the associated risk. The Company entered into a series of forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had an unrealized pre-tax gain of $2.6 and an unrealized pre-tax loss of $1.6 at June 30, 2018 and September 30, 2017 , respectively, on these forward currency contracts accounted for as cash flow hedges, which are included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at June 30, 2018 levels over the next 12 months, the majority of the pre-tax gain included in AOCI at June 30, 2018 is expected to be included in Other expense (income), net. Contract maturities for these hedges extend into fiscal 2019. There were 64 open foreign currency contracts at June 30, 2018 with a total notional value of $137.8 . Derivatives not Designated as Hedges The Company entered into foreign currency derivative contracts which are not designated as cash flow hedges for accounting purposes to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures, thus they are not subject to significant market risk. The change in estimated fair value of the foreign currency contracts for the three and nine months ended June 30, 2018 resulted in gains of $3.0 and $0.2 , respectively, and was recorded in Other expense (income), net. The change in estimated fair value of the foreign currency contracts for the three and nine months ended June 30, 2017 resulted in gains of $1.6 and $2.0 , respectively. There were four open foreign currency derivative contracts which were not designated as cash flow hedges at June 30, 2018 , with a total notional value of $48.0 . The following table provides estimated fair values of derivative instruments: Fair Value of Asset (Liability) (1) June 30, 2018 September 30, 2017 Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 2.6 $ (1.6 ) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 1.1 $ 0.4 (1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities. The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended June 30, Nine Months Ended June 30, 2018 2017 2018 2017 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in OCI (1) $ 5.4 $ (1.5 ) $ 1.7 $ 6.7 Gain (loss) reclassified from AOCI into income (effective portion) (1) (2) (1.0 ) 1.1 (2.5 ) 2.5 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ 3.0 $ 1.6 $ 0.2 $ 2.0 (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk. (2) Gain (loss) was recorded in Other expense (income), net. The following table provides financial assets and liabilities for balance sheet offsetting: At June 30, 2018 At September 30, 2017 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 4.0 $ — $ 2.5 $ (3.7 ) Gross amounts offset in the balance sheet (0.3 ) — (0.1 ) 0.1 Net amounts of assets (liabilities) presented in the balance sheet $ 3.7 $ — $ 2.4 $ (3.6 ) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities. Fair Value Hierarchy Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity's own assumptions or external inputs from inactive markets. Under the fair value accounting guidance hierarchy, an entity is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The following table sets forth the Company's financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as level 2 within the fair value hierarchy: June 30, September 30, Assets (Liabilities) at estimated fair value: Deferred compensation $ (47.6 ) $ (60.9 ) Derivatives - foreign currency contracts 3.7 (1.2 ) Net liabilities at estimated fair value $ (43.9 ) $ (62.1 ) At June 30, 2018 and September 30, 2017 , the Company had no level 1 or level 3 financial assets or liabilities, other than pension plan assets. At June 30, 2018 and September 30, 2017 , the fair market value of fixed rate long-term debt was $1,059.5 and $1,143.8 , respectively, compared to its carrying value of $1,096.5 and $ 1,095.7 , respectively. The estimated fair value of the long-term debt is estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of variable-rate debt, excluding revolving credit facilities, which consists of bank debt, was $185.0 compared to its carrying value of $184.9 and $184.7 at June 30, 2018 and September 30, 2017, respectively. The estimated fair value is equal to the face value of the debt. The estimated fair value of long-term debt, excluding revolving credit facilities, has been determined based on level 2 inputs. Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Company's revolving credit facilities, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of cash and cash equivalents, short-term borrowings and the revolving credit agreements have been determined based on level 2 inputs. At June 30, 2018 , the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates and remaining maturities. The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company and its affiliates are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated, and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, if the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is not reasonably likely to be material to the Company's financial position, results of operations or cash flows, taking into account established accruals for estimated liabilities.

Segment Data

Segment Data	9 Months Ended
	Jun. 30, 2018
Segment Reporting [Abstract]
Segment Data	Segment Data Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, impairment charges, Jack Black acquisition and integration costs, costs associated with restructuring initiatives, the gain on the sale of the Playtex gloves business and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance. The Company's operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and in most cases a combined sales force and management teams. The Company applies a fully allocated cost basis, in which shared business functions are allocated between the segments. Such allocations are estimates, and do not represent the costs of such services if performed on a stand-alone basis. Segment net sales and profitability are presented below: Three Months Ended Nine Months Ended 2018 2017 2018 2017 Net Sales Wet Shave $ 341.1 $ 358.5 $ 980.4 $ 1,007.3 Sun and Skin Care 162.8 161.1 374.2 369.3 Feminine Care 84.1 86.4 247.0 258.7 All Other 32.6 31.5 95.4 98.2 Total net sales $ 620.6 $ 637.5 $ 1,697.0 $ 1,733.5 Segment Profit Wet Shave $ 56.0 $ 59.8 $ 180.5 $ 205.0 Sun and Skin Care 34.1 42.4 76.9 94.1 Feminine Care 11.1 7.6 26.2 17.5 All Other 5.5 6.7 17.0 21.3 Total segment profit 106.7 116.5 300.6 337.9 General corporate and other expenses (17.5 ) (18.2 ) (54.7 ) (58.1 ) Impairment charge (24.4 ) — (24.4 ) — Restructuring and related costs (1) (15.9 ) (12.8 ) (19.6 ) (25.6 ) Jack Black integration costs (2.3 ) — (4.9 ) — Sale of Playtex gloves (0.6 ) — 15.3 — Amortization of intangibles (4.6 ) (4.0 ) (13.2 ) (12.1 ) Interest and other expense, net (20.0 ) (16.0 ) (58.8 ) (42.2 ) Total earnings before income taxes $ 21.4 $ 65.5 $ 140.3 $ 199.9 (1) Includes pre-tax Selling, general and administrative expense of $0.5 for the three and nine months ended June 30, 2018, associated with certain information technology enablement expenses related to Project Fuel. Includes pre-tax Cost of products sold of $0.3 and $0.7 for the three and nine months ended June 30, 2017, respectively, associated with obsolescence charges related to the exit of certain non-core product lines as a part of the 2013 Restructuring. Supplemental product information is presented below for net sales: Three Months Ended Nine Months Ended 2018 2017 2018 2017 Razors and blades $ 304.6 $ 319.3 $ 877.5 $ 896.2 Sun care products 132.1 136.9 297.5 305.8 Tampons, pads and liners 84.1 86.4 247.0 258.7 Shaving gels and creams 36.5 39.2 102.9 111.1 Infant care and other 32.6 31.5 95.4 98.2 Skin care products 30.7 24.2 76.7 63.5 Total net sales $ 620.6 $ 637.5 $ 1,697.0 $ 1,733.5

Guarantor and Non-Guarantor Fin

Guarantor and Non-Guarantor Financial Information	9 Months Ended
	Jun. 30, 2018
Guarantor and Non-Guarantor Financial Information [Abstract]
Guarantor and Non-Guarantor Financial Information	Guarantor and Non-Guarantor Financial Information The Company's senior notes issued in May 2011 and May 2012 (collectively, the "Notes") are fully and unconditionally guaranteed on a joint and several basis by the Company's existing and future direct and indirect domestic subsidiaries that are guarantors of any of the Company's credit agreements or other indebtedness for borrowed money (the "Guarantors"). The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee the Company's obligations under the Notes and substantially all of the Company's other outstanding indebtedness. The Company's subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company's other indebtedness (collectively, the "Non-Guarantors"), do not guarantee the Notes. The subsidiary guarantee with respect to the Notes is subject to release upon sale of all of the capital stock of the Subsidiary Guarantor; if the guarantee under the Company's credit agreements and other indebtedness for borrowed money is released or discharged (other than due to payment under such guarantee); or when the requirements for legal defeasance are satisfied or the obligations are discharged in accordance with the indenture. Set forth below are the condensed consolidating financial statements presenting the results of operations, financial position and cash flows of Edgewell Personal Care Company (the “Parent Company”), the Guarantors on a combined basis, the Non-Guarantors on a combined basis and eliminations necessary to arrive at the information for the Company, as reported on a consolidated basis. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among the Parent Company, the Guarantors and the Non-Guarantors. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 425.1 $ 278.0 $ (82.5 ) $ 620.6 Cost of products sold — 236.9 163.5 (82.5 ) 317.9 Gross profit — 188.2 114.5 — 302.7 Selling, general and administrative expense — 61.2 39.5 — 100.7 Advertising and sales promotion expense — 70.0 35.3 — 105.3 Research and development expense — 14.9 — — 14.9 Impairment charge — 24.4 — — 24.4 Restructuring charges — 13.4 2.0 — 15.4 Sale of Playtex gloves — 0.6 — — 0.6 Interest expense associated with debt 13.4 2.8 0.3 — 16.5 Other expense, net — 0.8 2.7 — 3.5 Intercompany service fees — (3.5 ) 3.5 — — Equity in earnings of subsidiaries (21.9 ) (25.7 ) — 47.6 — Earnings before income taxes 8.5 29.3 31.2 (47.6 ) 21.4 Income tax (benefit) provision (3.6 ) 7.4 5.5 — 9.3 Net earnings $ 12.1 $ 21.9 $ 25.7 $ (47.6 ) $ 12.1 Statement of Comprehensive Income: Net earnings $ 12.1 $ 21.9 $ 25.7 $ (47.6 ) $ 12.1 Other comprehensive loss, net of tax (30.0 ) (30.0 ) (30.5 ) 60.5 (30.0 ) Total comprehensive loss $ (17.9 ) $ (8.1 ) $ (4.8 ) $ 12.9 $ (17.9 ) EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Nine Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 1,143.9 $ 788.5 $ (235.4 ) $ 1,697.0 Cost of products sold — 661.9 465.4 (235.4 ) 891.9 Gross profit — 482.0 323.1 — 805.1 Selling, general and administrative expense — 187.9 113.5 — 301.4 Advertising and sales promotion expense — 139.3 90.6 — 229.9 Research and development expense — 46.5 — — 46.5 Impairment charge — 24.4 — — 24.4 Restructuring charges — 15.8 3.3 — 19.1 Sale of Playtex gloves — (15.3 ) — — (15.3 ) Interest expense associated with debt 40.1 11.6 0.8 — 52.5 Other expense, net — 1.8 4.5 — 6.3 Intercompany service fees — (14.6 ) 14.6 — — Equity in earnings of subsidiaries (113.2 ) (79.1 ) — 192.3 — Earnings before income taxes 73.1 163.7 95.8 (192.3 ) 140.3 Income tax (benefit) provision (10.8 ) 50.5 16.7 — 56.4 Net earnings $ 83.9 $ 113.2 $ 79.1 $ (192.3 ) $ 83.9 Statement of Comprehensive Income: Net earnings $ 83.9 $ 113.2 $ 79.1 $ (192.3 ) $ 83.9 Other comprehensive loss, net of tax (4.9 ) (4.9 ) (6.5 ) 11.4 (4.9 ) Total comprehensive income $ 79.0 $ 108.3 $ 72.6 $ (180.9 ) $ 79.0 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended June 30, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 447.8 $ 291.4 $ (101.7 ) $ 637.5 Cost of products sold — 247.6 169.5 (101.7 ) 315.4 Gross profit — 200.2 121.9 — 322.1 Selling, general and administrative expense — 63.6 33.9 — 97.5 Advertising and sales promotion expense — 76.9 37.3 — 114.2 Research and development expense — 16.3 0.1 — 16.4 Restructuring charges — 2.5 10.0 — 12.5 Interest expense associated with debt 13.4 4.0 0.2 — 17.6 Other income, net — — (1.6 ) — (1.6 ) Intercompany service fees — (4.7 ) 4.7 — — Equity in earnings of subsidiaries (64.1 ) (31.5 ) — 95.6 — Earnings before income taxes 50.7 73.1 37.3 (95.6 ) 65.5 Income tax (benefit) provision (4.2 ) 9.0 5.8 — 10.6 Net earnings $ 54.9 $ 64.1 $ 31.5 $ (95.6 ) $ 54.9 Statement of Comprehensive Income: Net earnings 54.9 64.1 31.5 (95.6 ) 54.9 Other comprehensive income, net of tax 40.6 40.6 40.2 (80.8 ) 40.6 Total comprehensive income $ 95.5 $ 104.7 $ 71.7 $ (176.4 ) $ 95.5 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Nine Months Ended June 30, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 1,224.1 $ 799.3 $ (289.9 ) $ 1,733.5 Cost of products sold — 689.1 474.6 (289.9 ) 873.8 Gross profit — 535.0 324.7 — 859.7 Selling, general and administrative expense — 192.2 103.0 — 295.2 Advertising and sales promotion expense — 159.8 87.5 — 247.3 Research and development expense — 49.6 0.6 — 50.2 Restructuring charges — 7.4 17.5 — 24.9 Interest expense associated with debt 40.1 11.1 1.1 — 52.3 Other income, net — — (10.1 ) — (10.1 ) Intercompany service fees — (17.2 ) 17.2 — — Equity in earnings of subsidiaries (180.1 ) (88.9 ) — 269.0 — Earnings before income taxes 140.0 221.0 107.9 (269.0 ) 199.9 Income tax (benefit) provision (14.1 ) 40.9 19.0 — 45.8 Net earnings $ 154.1 $ 180.1 $ 88.9 $ (269.0 ) $ 154.1 Statement of Comprehensive Income: Net earnings 154.1 180.1 88.9 (269.0 ) 154.1 Other comprehensive income, net of tax 20.9 20.9 19.1 (40.0 ) 20.9 Total comprehensive income $ 175.0 $ 201.0 $ 108.0 $ (309.0 ) $ 175.0 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 5.6 $ 212.9 $ — $ 218.5 Trade receivables, net — 46.5 179.1 — 225.6 Inventories — 191.3 150.1 — 341.4 Other current assets — 49.6 85.7 — 135.3 Total current assets — 293.0 627.8 — 920.8 Investment in subsidiaries 3,725.5 1,179.5 — (4,905.0 ) — Intercompany receivables, net (1) — 849.0 56.8 (905.8 ) — Property, plant and equipment, net — 319.2 108.3 — 427.5 Goodwill — 1,037.5 413.2 — 1,450.7 Other intangible assets, net — 889.8 214.4 — 1,104.2 Other assets 1.1 0.1 32.2 — 33.4 Total assets $ 3,726.6 $ 4,568.1 $ 1,452.7 $ (5,810.8 ) $ 3,936.6 Liabilities and Shareholders' Equity Current liabilities $ 6.4 $ 506.3 $ 224.0 $ — $ 736.7 Intercompany payables, net (1) 905.8 — — (905.8 ) — Long-term debt 1,096.5 — — — 1,096.5 Deferred income tax liabilities — 115.9 35.1 — 151.0 Other liabilities — 220.4 14.1 — 234.5 Total liabilities 2,008.7 842.6 273.2 (905.8 ) 2,218.7 Total shareholders' equity 1,717.9 3,725.5 1,179.5 (4,905.0 ) 1,717.9 Total liabilities and shareholders' equity $ 3,726.6 $ 4,568.1 $ 1,452.7 $ (5,810.8 ) $ 3,936.6 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS September 30, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 6.4 $ 496.5 $ — $ 502.9 Trade receivables, net — 34.4 189.7 — 224.1 Inventories — 198.7 134.8 — 333.5 Other current assets — 46.3 79.4 — 125.7 Total current assets — 285.8 900.4 — 1,186.2 Investment in subsidiaries 3,554.1 1,363.2 — (4,917.3 ) — Intercompany receivables, net (1) — 644.2 54.7 (698.9 ) — Property, plant and equipment, net — 335.7 117.7 — 453.4 Goodwill — 1,061.9 384.0 — 1,445.9 Other intangible assets, net — 900.3 171.4 — 1,071.7 Other assets 1.6 0.1 29.9 — 31.6 Total assets $ 3,555.7 $ 4,591.2 $ 1,658.1 $ (5,616.2 ) $ 4,188.8 Liabilities and Shareholders' Equity Current liabilities $ 19.3 $ 259.8 $ 245.3 $ — $ 524.4 Intercompany payables, net (1) 698.9 — — (698.9 ) — Long-term debt 1,095.4 430.0 — — 1,525.4 Deferred income tax liabilities — 147.6 34.2 — 181.8 Other liabilities 0.4 199.7 15.4 — 215.5 Total liabilities 1,814.0 1,037.1 294.9 (698.9 ) 2,447.1 Total shareholders' equity 1,741.7 3,554.1 1,363.2 (4,917.3 ) 1,741.7 Total liabilities and shareholders' equity $ 3,555.7 $ 4,591.2 $ 1,658.1 $ (5,616.2 ) $ 4,188.8 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Nine Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from operations $ 126.6 $ 343.2 $ 73.7 $ (350.2 ) $ 193.3 Cash Flow from Investing Activities Capital expenditures — (31.3 ) (10.5 ) — (41.8 ) Acquisitions, net of cash acquired — (90.2 ) — — (90.2 ) Playtex glove sale — 19.0 — — 19.0 Proceeds from sale of assets — 4.7 — — 4.7 Net cash used by investing activities — (97.8 ) (10.5 ) — (108.3 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 477.0 — — 477.0 Cash payments on debt with original maturities greater than 90 days — (722.0 ) — — (722.0 ) Net (decrease) increase in debt with original maturities of 90 days or less — (1.2 ) 1.4 — 0.2 Common shares purchased (124.4 ) — — — (124.4 ) Intercompany dividend — — (350.2 ) 350.2 — Employee shares withheld for taxes (2.2 ) — — — (2.2 ) Net cash used by financing activities (126.6 ) (246.2 ) (348.8 ) 350.2 (371.4 ) Effect of exchange rate changes on cash — — 2.0 — 2.0 Net decrease in cash and cash equivalents — (0.8 ) (283.6 ) — (284.4 ) Cash and cash equivalents, beginning of period — 6.4 496.5 — 502.9 Cash and cash equivalents, end of period $ — $ 5.6 $ 212.9 $ — $ 218.5 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Nine Months Ended June 30, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from operations $ 108.3 $ 8.3 $ 88.4 $ (70.0 ) $ 135.0 Cash Flow from Investing Activities Capital expenditures — (36.0 ) (9.4 ) — (45.4 ) Acquisitions, net of cash acquired — — (34.0 ) — (34.0 ) Proceeds from sale of assets — 5.9 — — 5.9 Net cash used by investing activities — (30.1 ) (43.4 ) — (73.5 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 181.0 — — 181.0 Cash payments on debt with original maturities greater than 90 days — (146.0 ) (277.0 ) — (423.0 ) Net increase (decrease) in debt with original maturities of 90 days or less — 0.7 (0.6 ) — 0.1 Common shares purchased (94.6 ) — — — (94.6 ) Intercompany dividends — — (70.0 ) 70.0 — Employee shares withheld for taxes (15.6 ) — — — (15.6 ) Excess tax benefits from share-based payments 1.9 — — — 1.9 Net cash (used by) from financing activities (108.3 ) 35.7 (347.6 ) 70.0 (350.2 ) Effect of exchange rate changes on cash — — 4.7 — 4.7 Net increase (decrease) in cash and cash equivalents — 13.9 (297.9 ) — (284.0 ) Cash and cash equivalents, beginning of period — 5.8 733.1 — 738.9 Cash and cash equivalents, end of period $ — $ 19.7 $ 435.2 $ — $ 454.9

Restructuring Charges (Tables)

Restructuring Charges (Tables)	9 Months Ended
	Jun. 30, 2018
Restructuring Charges [Abstract]
Schedule of Charges Related to Restructuring Activities	Expenses incurred under the 2013 Restructuring are reflected below, including the estimated impact of allocating such charges to segment results. 2013 Restructuring charges were only allocated to the Company's Wet Shave, Sun and Skin Care and Feminine Care segments for the three and nine months ended June 30, 2017. The Company does not include restructuring costs in the results of its reportable segments. Three Months Ended June 30, 2017 Wet Sun and Skin Care Feminine Care Total 2013 Restructuring Severance and related benefit costs $ 0.4 $ — $ 2.0 $ 2.4 Asset impairment and accelerated depreciation — — 3.6 3.6 Consulting, project implementation and management and other exit costs 2.9 — 3.6 6.5 Total 2013 Restructuring $ 3.3 $ — $ 9.2 $ 12.5 Nine Months Ended June 30, 2017 Wet Sun and Skin Care Feminine Care Total 2013 Restructuring Severance and related benefit costs $ 1.1 $ — $ 4.4 $ 5.5 Asset impairment and accelerated depreciation — — 6.4 6.4 Consulting, project implementation and management and other exit costs 6.8 0.1 6.1 13.0 Total 2013 Restructuring $ 7.9 $ 0.1 $ 16.9 $ 24.9 The Company incurred restructuring charges of $15.9 and $19.6 related to Project Fuel in the three and nine months ended June 30, 2018, respectively. Three Months Ended June 30, 2018 Wet Sun and Skin Care Feminine Care All Other Corporate Total Restructuring Severance and related benefit costs $ 1.6 $ 0.2 $ 1.0 $ 0.1 $ — $ 2.9 Consulting, project implementation and management and other exit costs 2.0 0.2 — — 10.8 13.0 Total Restructuring $ 3.6 $ 0.4 $ 1.0 $ 0.1 $ 10.8 $ 15.9 Nine Months Ended June 30, 2018 Wet Sun and Skin Care Feminine Care All Other Corporate Total Restructuring Severance and related benefit costs $ 3.1 $ 0.9 $ 1.1 $ 0.1 $ — $ 5.2 Consulting, project implementation and management and other exit costs 2.0 0.2 — — 12.2 14.4 Total Restructuring $ 5.1 $ 1.1 $ 1.1 $ 0.1 $ 12.2 $ 19.6
Schedule of Restructuring Activities and Related Accruals	The following table summarizes Project Fuel and 2013 Restructuring activities and related accruals (excluding certain obsolescence charges related to the 2013 Restructuring): Utilized October 1, 2017 Charge to Other (1) Cash Non-Cash June 30, 2018 Restructuring Severance and termination related costs $ 2.4 $ 5.2 $ — $ (4.6 ) $ — $ 3.0 Other related costs — 14.4 — (7.3 ) — 7.1 Total Restructuring $ 2.4 $ 19.6 $ — $ (11.9 ) $ — $ 10.1 Utilized October 1, 2016 Charge to Other (1) Cash Non-Cash September 30, 2017 Restructuring Severance and termination related costs $ 16.7 $ 6.5 $ (0.3 ) $ (20.5 ) $ — $ 2.4 Asset impairment and accelerated depreciation — 6.9 — — (6.9 ) — Other related costs — 16.2 — (16.2 ) — — Total Restructuring $ 16.7 $ 29.6 $ (0.3 ) $ (36.7 ) $ (6.9 ) $ 2.4 (1) Includes the impact of currency translation.	[1]
[1]	(1)Includes the impact of currency translation.

Earnings per Share (Tables)

Earnings per Share (Tables)	9 Months Ended
	Jun. 30, 2018
Earnings Per Share [Abstract]
Schedule of Weighted-Average Shares Outstanding	Following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended June 30, Nine Months Ended June 30, 2018 2017 2018 2017 Basic weighted-average shares outstanding 54.0 57.2 54.5 57.4 Effect of dilutive securities: RSE awards 0.1 0.3 0.1 0.3 Total dilutive securities 0.1 0.3 0.1 0.3 Diluted weighted-average shares outstanding 54.1 57.5 54.6 57.7

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table sets forth goodwill by segment: Wet Sun and Skin Feminine All Total Balance at October 1, 2017 $ 971.2 $ 195.6 $ 209.5 $ 69.6 $ 1,445.9 Acquisition of Jack Black — 34.3 — — 34.3 Cumulative translation adjustment (2.6 ) (0.3 ) (2.2 ) — (5.1 ) Impairment charge — — — (24.4 ) (24.4 ) Balance at June 30, 2018 $ 968.6 $ 229.6 $ 207.3 $ 45.2 $ 1,450.7 Accumulated goodwill impairment losses totaled $24.4 at June 30, 2018 in the All Other segment.
Schedule of Amortizable Intangible Assets	Total amortizable intangible assets were as follows: June 30, 2018 September 30, 2017 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 206.7 $ 23.0 $ 183.7 $ 188.6 $ 16.0 $ 172.6 Technology and patents 79.0 75.7 3.3 77.9 74.4 3.5 Customer related and other 179.7 94.5 85.2 151.5 89.8 61.7 Total amortizable intangible assets $ 465.4 $ 193.2 $ 272.2 $ 418.0 $ 180.2 $ 237.8

Supplemental Balance Sheet In27

Supplemental Balance Sheet Information (Tables)	9 Months Ended
	Jun. 30, 2018
Supplemental Balance Sheet Information [Abstract]
Supplement Balance Sheet Information	June 30, September 30, Inventories Raw materials and supplies $ 47.0 $ 50.6 Work in process 60.4 60.9 Finished products 234.0 222.0 Total inventories $ 341.4 $ 333.5 Other Current Assets Miscellaneous receivables $ 15.2 $ 16.9 Prepaid expenses 77.4 55.6 Value added tax collectible from customers 26.9 25.2 Income taxes receivable 11.0 24.7 Other 4.8 3.3 Total other current assets $ 135.3 $ 125.7 Property, Plant and Equipment Land $ 19.2 $ 19.3 Buildings 142.4 139.1 Machinery and equipment 960.6 947.4 Capitalized software costs 48.3 42.3 Construction in progress 51.7 49.7 Total gross property 1,222.2 1,197.8 Accumulated depreciation (794.7 ) (744.4 ) Total property, plant and equipment, net $ 427.5 $ 453.4 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 49.4 $ 32.2 Accrued trade allowances 24.7 24.6 Accrued salaries, vacations and incentive compensation 46.6 40.6 Income taxes payable 24.2 18.3 Returns reserve 49.8 53.3 Restructuring reserve 10.1 3.0 Value added tax payable 7.8 5.8 Deferred compensation 4.7 13.8 Other 79.7 89.8 Total other current liabilities $ 297.0 $ 281.4 Other Liabilities Pensions and other retirement benefits $ 97.2 $ 109.4 Deferred compensation 43.0 47.3 Long-term income taxes payable 36.1 — Other non-current liabilities 58.2 58.8 Total other liabilities $ 234.5 $ 215.5

Debt (Tables)

Debt (Tables)	9 Months Ended
	Jun. 30, 2018
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The detail of long-term debt was as follows: June 30, September 30, Senior notes, fixed interest rate of 4.7%, due 2021, net (1) $ 598.6 $ 598.3 Senior notes, fixed interest rate of 4.7%, due 2022, net (1) (2) 497.9 497.4 U.S. revolving credit facility due 2020 — 245.0 Term loan, due 2019, net (1) 184.9 184.7 Total long-term debt, including current maturities 1,281.4 1,525.4 Less current portion 184.9 — Total long-term debt $ 1,096.5 $ 1,525.4 (1) At June 30, 2018 , the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.4 , $1.6 and $0.1 , respectively. At September 30, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.7 , $1.9 and $0.3 , respectively. (2) At June 30, 2018 and September 30, 2017, the balance for the senior notes due 2022 is reflected net of discounts of $0.5 and $0.7 , respectively.

Retirement Plans (Tables)

Retirement Plans (Tables)	9 Months Ended
	Jun. 30, 2018
Retirement Benefits [Abstract]
Schedule of Net Periodic Pension and Postretirement Benefit (Credit) Cost	The Company's net periodic pension and postretirement benefit (credit) cost for these plans was as follows: Three Months Ended June 30, Nine Months Ended June 30, 2018 2017 2018 2017 Service cost $ 1.5 $ 1.8 $ 4.6 $ 5.5 Interest cost 4.3 3.7 12.9 11.2 Expected return on plan assets (7.9 ) (7.9 ) (23.8 ) (23.8 ) Recognized net actuarial loss 1.1 1.6 3.4 4.6 Settlement loss recognized — — — 0.3 Net periodic benefit (credit) cost $ (1.0 ) $ (0.8 ) $ (2.9 ) $ (2.2 )

Accumulated Other Comprehensi30

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Jun. 30, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Loss	The following table presents the changes in accumulated other comprehensive loss ("AOCI"), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2017 $ (29.0 ) $ (101.3 ) $ (1.1 ) $ (131.4 ) OCI before reclassifications (1) (10.4 ) 0.2 1.2 (9.0 ) Reclassifications to earnings — 2.4 1.7 4.1 Balance at June 30, 2018 $ (39.4 ) $ (98.7 ) $ 1.8 $ (136.3 ) Foreign Pension and Hedging Total Balance at October 1, 2016 $ (68.1 ) $ (126.3 ) $ (2.8 ) $ (197.2 ) OCI before reclassifications (1) 15.1 (0.1 ) 4.3 19.3 Reclassifications to earnings — 3.2 (1.6 ) 1.6 Balance at June 30, 2017 $ (53.0 ) $ (123.2 ) $ (0.1 ) $ (176.3 ) (1) OCI is defined as other comprehensive income (loss).
Schedule of Reclassifications out of Accumulated Other Comprehensive Loss	The following table presents the reclassifications out of AOCI: For the Three Months Ended For the Nine Months Ended June 30, Affected Line Item in the Condensed Consolidated Statements of Earnings Details of AOCI Components 2018 2017 2018 2017 (Loss) / gain on cash flow hedges Foreign exchange contracts $ (1.0 ) $ 1.1 $ (2.5 ) $ 2.5 Other expense (income), net (1.0 ) 1.1 (2.5 ) 2.5 Total before tax 0.4 (0.4 ) 0.8 (0.9 ) Tax expense (0.6 ) 0.7 (1.7 ) 1.6 Net of tax Amortization of defined benefit pension and postretirement items Actuarial losses (1.1 ) (1.6 ) (3.4 ) (4.6 ) (1) Settlement loss recognized — — — (0.3 ) (1) (1.1 ) (1.6 ) (3.4 ) (4.9 ) Total before tax 0.3 0.6 1.0 1.7 Tax expense (0.8 ) (1.0 ) (2.4 ) (3.2 ) Net of tax Total reclassifications for the period $ (1.4 ) $ (0.3 ) $ (4.1 ) $ (1.6 ) Net of tax (1) These AOCI components are included in the computation of net periodic benefit cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris31

Financial Instruments and Risk Management (Tables)	9 Months Ended
	Jun. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Derivative Instruments	The following table provides estimated fair values of derivative instruments: Fair Value of Asset (Liability) (1) June 30, 2018 September 30, 2017 Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 2.6 $ (1.6 ) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 1.1 $ 0.4 (1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Gains and Losses on Derivative Instruments	The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended June 30, Nine Months Ended June 30, 2018 2017 2018 2017 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in OCI (1) $ 5.4 $ (1.5 ) $ 1.7 $ 6.7 Gain (loss) reclassified from AOCI into income (effective portion) (1) (2) (1.0 ) 1.1 (2.5 ) 2.5 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ 3.0 $ 1.6 $ 0.2 $ 2.0 (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk. (2) Gain (loss) was recorded in Other expense (income), net.
Schedule of Offsetting Assets and Liabilities	The following table provides financial assets and liabilities for balance sheet offsetting: At June 30, 2018 At September 30, 2017 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 4.0 $ — $ 2.5 $ (3.7 ) Gross amounts offset in the balance sheet (0.3 ) — (0.1 ) 0.1 Net amounts of assets (liabilities) presented in the balance sheet $ 3.7 $ — $ 2.4 $ (3.6 ) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company's financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as level 2 within the fair value hierarchy: June 30, September 30, Assets (Liabilities) at estimated fair value: Deferred compensation $ (47.6 ) $ (60.9 ) Derivatives - foreign currency contracts 3.7 (1.2 ) Net liabilities at estimated fair value $ (43.9 ) $ (62.1 )

Segment Data (Tables)

Segment Data (Tables)	9 Months Ended
	Jun. 30, 2018
Segment Reporting [Abstract]
Schedule of Segment Sales and Profitability	Segment net sales and profitability are presented below: Three Months Ended Nine Months Ended 2018 2017 2018 2017 Net Sales Wet Shave $ 341.1 $ 358.5 $ 980.4 $ 1,007.3 Sun and Skin Care 162.8 161.1 374.2 369.3 Feminine Care 84.1 86.4 247.0 258.7 All Other 32.6 31.5 95.4 98.2 Total net sales $ 620.6 $ 637.5 $ 1,697.0 $ 1,733.5 Segment Profit Wet Shave $ 56.0 $ 59.8 $ 180.5 $ 205.0 Sun and Skin Care 34.1 42.4 76.9 94.1 Feminine Care 11.1 7.6 26.2 17.5 All Other 5.5 6.7 17.0 21.3 Total segment profit 106.7 116.5 300.6 337.9 General corporate and other expenses (17.5 ) (18.2 ) (54.7 ) (58.1 ) Impairment charge (24.4 ) — (24.4 ) — Restructuring and related costs (1) (15.9 ) (12.8 ) (19.6 ) (25.6 ) Jack Black integration costs (2.3 ) — (4.9 ) — Sale of Playtex gloves (0.6 ) — 15.3 — Amortization of intangibles (4.6 ) (4.0 ) (13.2 ) (12.1 ) Interest and other expense, net (20.0 ) (16.0 ) (58.8 ) (42.2 ) Total earnings before income taxes $ 21.4 $ 65.5 $ 140.3 $ 199.9 (1) Includes pre-tax Selling, general and administrative expense of $0.5 for the three and nine months ended June 30, 2018, associated with certain information technology enablement expenses related to Project Fuel. Includes pre-tax Cost of products sold of $0.3 and $0.7 for the three and nine months ended June 30, 2017, respectively, associated with obsolescence charges related to the exit of certain non-core product lines as a part of the 2013 Restructuring.
Schedule of Supplemental Product Information	Supplemental product information is presented below for net sales: Three Months Ended Nine Months Ended 2018 2017 2018 2017 Razors and blades $ 304.6 $ 319.3 $ 877.5 $ 896.2 Sun care products 132.1 136.9 297.5 305.8 Tampons, pads and liners 84.1 86.4 247.0 258.7 Shaving gels and creams 36.5 39.2 102.9 111.1 Infant care and other 32.6 31.5 95.4 98.2 Skin care products 30.7 24.2 76.7 63.5 Total net sales $ 620.6 $ 637.5 $ 1,697.0 $ 1,733.5

Guarantor and Non-Guarantor F33

Guarantor and Non-Guarantor Financial Information (Tables)	9 Months Ended
	Jun. 30, 2018
Guarantor and Non-Guarantor Financial Information [Abstract]
Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 425.1 $ 278.0 $ (82.5 ) $ 620.6 Cost of products sold — 236.9 163.5 (82.5 ) 317.9 Gross profit — 188.2 114.5 — 302.7 Selling, general and administrative expense — 61.2 39.5 — 100.7 Advertising and sales promotion expense — 70.0 35.3 — 105.3 Research and development expense — 14.9 — — 14.9 Impairment charge — 24.4 — — 24.4 Restructuring charges — 13.4 2.0 — 15.4 Sale of Playtex gloves — 0.6 — — 0.6 Interest expense associated with debt 13.4 2.8 0.3 — 16.5 Other expense, net — 0.8 2.7 — 3.5 Intercompany service fees — (3.5 ) 3.5 — — Equity in earnings of subsidiaries (21.9 ) (25.7 ) — 47.6 — Earnings before income taxes 8.5 29.3 31.2 (47.6 ) 21.4 Income tax (benefit) provision (3.6 ) 7.4 5.5 — 9.3 Net earnings $ 12.1 $ 21.9 $ 25.7 $ (47.6 ) $ 12.1 Statement of Comprehensive Income: Net earnings $ 12.1 $ 21.9 $ 25.7 $ (47.6 ) $ 12.1 Other comprehensive loss, net of tax (30.0 ) (30.0 ) (30.5 ) 60.5 (30.0 ) Total comprehensive loss $ (17.9 ) $ (8.1 ) $ (4.8 ) $ 12.9 $ (17.9 ) EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Nine Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 1,143.9 $ 788.5 $ (235.4 ) $ 1,697.0 Cost of products sold — 661.9 465.4 (235.4 ) 891.9 Gross profit — 482.0 323.1 — 805.1 Selling, general and administrative expense — 187.9 113.5 — 301.4 Advertising and sales promotion expense — 139.3 90.6 — 229.9 Research and development expense — 46.5 — — 46.5 Impairment charge — 24.4 — — 24.4 Restructuring charges — 15.8 3.3 — 19.1 Sale of Playtex gloves — (15.3 ) — — (15.3 ) Interest expense associated with debt 40.1 11.6 0.8 — 52.5 Other expense, net — 1.8 4.5 — 6.3 Intercompany service fees — (14.6 ) 14.6 — — Equity in earnings of subsidiaries (113.2 ) (79.1 ) — 192.3 — Earnings before income taxes 73.1 163.7 95.8 (192.3 ) 140.3 Income tax (benefit) provision (10.8 ) 50.5 16.7 — 56.4 Net earnings $ 83.9 $ 113.2 $ 79.1 $ (192.3 ) $ 83.9 Statement of Comprehensive Income: Net earnings $ 83.9 $ 113.2 $ 79.1 $ (192.3 ) $ 83.9 Other comprehensive loss, net of tax (4.9 ) (4.9 ) (6.5 ) 11.4 (4.9 ) Total comprehensive income $ 79.0 $ 108.3 $ 72.6 $ (180.9 ) $ 79.0 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended June 30, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 447.8 $ 291.4 $ (101.7 ) $ 637.5 Cost of products sold — 247.6 169.5 (101.7 ) 315.4 Gross profit — 200.2 121.9 — 322.1 Selling, general and administrative expense — 63.6 33.9 — 97.5 Advertising and sales promotion expense — 76.9 37.3 — 114.2 Research and development expense — 16.3 0.1 — 16.4 Restructuring charges — 2.5 10.0 — 12.5 Interest expense associated with debt 13.4 4.0 0.2 — 17.6 Other income, net — — (1.6 ) — (1.6 ) Intercompany service fees — (4.7 ) 4.7 — — Equity in earnings of subsidiaries (64.1 ) (31.5 ) — 95.6 — Earnings before income taxes 50.7 73.1 37.3 (95.6 ) 65.5 Income tax (benefit) provision (4.2 ) 9.0 5.8 — 10.6 Net earnings $ 54.9 $ 64.1 $ 31.5 $ (95.6 ) $ 54.9 Statement of Comprehensive Income: Net earnings 54.9 64.1 31.5 (95.6 ) 54.9 Other comprehensive income, net of tax 40.6 40.6 40.2 (80.8 ) 40.6 Total comprehensive income $ 95.5 $ 104.7 $ 71.7 $ (176.4 ) $ 95.5 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Nine Months Ended June 30, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 1,224.1 $ 799.3 $ (289.9 ) $ 1,733.5 Cost of products sold — 689.1 474.6 (289.9 ) 873.8 Gross profit — 535.0 324.7 — 859.7 Selling, general and administrative expense — 192.2 103.0 — 295.2 Advertising and sales promotion expense — 159.8 87.5 — 247.3 Research and development expense — 49.6 0.6 — 50.2 Restructuring charges — 7.4 17.5 — 24.9 Interest expense associated with debt 40.1 11.1 1.1 — 52.3 Other income, net — — (10.1 ) — (10.1 ) Intercompany service fees — (17.2 ) 17.2 — — Equity in earnings of subsidiaries (180.1 ) (88.9 ) — 269.0 — Earnings before income taxes 140.0 221.0 107.9 (269.0 ) 199.9 Income tax (benefit) provision (14.1 ) 40.9 19.0 — 45.8 Net earnings $ 154.1 $ 180.1 $ 88.9 $ (269.0 ) $ 154.1 Statement of Comprehensive Income: Net earnings 154.1 180.1 88.9 (269.0 ) 154.1 Other comprehensive income, net of tax 20.9 20.9 19.1 (40.0 ) 20.9 Total comprehensive income $ 175.0 $ 201.0 $ 108.0 $ (309.0 ) $ 175.0
Schedule of Condensed Consolidating Balance Sheets	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 5.6 $ 212.9 $ — $ 218.5 Trade receivables, net — 46.5 179.1 — 225.6 Inventories — 191.3 150.1 — 341.4 Other current assets — 49.6 85.7 — 135.3 Total current assets — 293.0 627.8 — 920.8 Investment in subsidiaries 3,725.5 1,179.5 — (4,905.0 ) — Intercompany receivables, net (1) — 849.0 56.8 (905.8 ) — Property, plant and equipment, net — 319.2 108.3 — 427.5 Goodwill — 1,037.5 413.2 — 1,450.7 Other intangible assets, net — 889.8 214.4 — 1,104.2 Other assets 1.1 0.1 32.2 — 33.4 Total assets $ 3,726.6 $ 4,568.1 $ 1,452.7 $ (5,810.8 ) $ 3,936.6 Liabilities and Shareholders' Equity Current liabilities $ 6.4 $ 506.3 $ 224.0 $ — $ 736.7 Intercompany payables, net (1) 905.8 — — (905.8 ) — Long-term debt 1,096.5 — — — 1,096.5 Deferred income tax liabilities — 115.9 35.1 — 151.0 Other liabilities — 220.4 14.1 — 234.5 Total liabilities 2,008.7 842.6 273.2 (905.8 ) 2,218.7 Total shareholders' equity 1,717.9 3,725.5 1,179.5 (4,905.0 ) 1,717.9 Total liabilities and shareholders' equity $ 3,726.6 $ 4,568.1 $ 1,452.7 $ (5,810.8 ) $ 3,936.6 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS September 30, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 6.4 $ 496.5 $ — $ 502.9 Trade receivables, net — 34.4 189.7 — 224.1 Inventories — 198.7 134.8 — 333.5 Other current assets — 46.3 79.4 — 125.7 Total current assets — 285.8 900.4 — 1,186.2 Investment in subsidiaries 3,554.1 1,363.2 — (4,917.3 ) — Intercompany receivables, net (1) — 644.2 54.7 (698.9 ) — Property, plant and equipment, net — 335.7 117.7 — 453.4 Goodwill — 1,061.9 384.0 — 1,445.9 Other intangible assets, net — 900.3 171.4 — 1,071.7 Other assets 1.6 0.1 29.9 — 31.6 Total assets $ 3,555.7 $ 4,591.2 $ 1,658.1 $ (5,616.2 ) $ 4,188.8 Liabilities and Shareholders' Equity Current liabilities $ 19.3 $ 259.8 $ 245.3 $ — $ 524.4 Intercompany payables, net (1) 698.9 — — (698.9 ) — Long-term debt 1,095.4 430.0 — — 1,525.4 Deferred income tax liabilities — 147.6 34.2 — 181.8 Other liabilities 0.4 199.7 15.4 — 215.5 Total liabilities 1,814.0 1,037.1 294.9 (698.9 ) 2,447.1 Total shareholders' equity 1,741.7 3,554.1 1,363.2 (4,917.3 ) 1,741.7 Total liabilities and shareholders' equity $ 3,555.7 $ 4,591.2 $ 1,658.1 $ (5,616.2 ) $ 4,188.8 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.
Schedule of Condensed Consolidating Statements of Cash Flows	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Nine Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from operations $ 126.6 $ 343.2 $ 73.7 $ (350.2 ) $ 193.3 Cash Flow from Investing Activities Capital expenditures — (31.3 ) (10.5 ) — (41.8 ) Acquisitions, net of cash acquired — (90.2 ) — — (90.2 ) Playtex glove sale — 19.0 — — 19.0 Proceeds from sale of assets — 4.7 — — 4.7 Net cash used by investing activities — (97.8 ) (10.5 ) — (108.3 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 477.0 — — 477.0 Cash payments on debt with original maturities greater than 90 days — (722.0 ) — — (722.0 ) Net (decrease) increase in debt with original maturities of 90 days or less — (1.2 ) 1.4 — 0.2 Common shares purchased (124.4 ) — — — (124.4 ) Intercompany dividend — — (350.2 ) 350.2 — Employee shares withheld for taxes (2.2 ) — — — (2.2 ) Net cash used by financing activities (126.6 ) (246.2 ) (348.8 ) 350.2 (371.4 ) Effect of exchange rate changes on cash — — 2.0 — 2.0 Net decrease in cash and cash equivalents — (0.8 ) (283.6 ) — (284.4 ) Cash and cash equivalents, beginning of period — 6.4 496.5 — 502.9 Cash and cash equivalents, end of period $ — $ 5.6 $ 212.9 $ — $ 218.5 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Nine Months Ended June 30, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from operations $ 108.3 $ 8.3 $ 88.4 $ (70.0 ) $ 135.0 Cash Flow from Investing Activities Capital expenditures — (36.0 ) (9.4 ) — (45.4 ) Acquisitions, net of cash acquired — — (34.0 ) — (34.0 ) Proceeds from sale of assets — 5.9 — — 5.9 Net cash used by investing activities — (30.1 ) (43.4 ) — (73.5 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 181.0 — — 181.0 Cash payments on debt with original maturities greater than 90 days — (146.0 ) (277.0 ) — (423.0 ) Net increase (decrease) in debt with original maturities of 90 days or less — 0.7 (0.6 ) — 0.1 Common shares purchased (94.6 ) — — — (94.6 ) Intercompany dividends — — (70.0 ) 70.0 — Employee shares withheld for taxes (15.6 ) — — — (15.6 ) Excess tax benefits from share-based payments 1.9 — — — 1.9 Net cash (used by) from financing activities (108.3 ) 35.7 (347.6 ) 70.0 (350.2 ) Effect of exchange rate changes on cash — — 4.7 — 4.7 Net increase (decrease) in cash and cash equivalents — 13.9 (297.9 ) — (284.0 ) Cash and cash equivalents, beginning of period — 5.8 733.1 — 738.9 Cash and cash equivalents, end of period $ — $ 19.7 $ 435.2 $ — $ 454.9

Background and Basis of Prese34

Background and Basis of Presentation (Details) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018USD ($)brandscountry	Jun. 30, 2017USD ($)	Jun. 30, 2018USD ($)brandscountry	Jun. 30, 2017USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax provision	$ 9.3	$ 10.6	$ 56.4	$ 45.8
Employee shares withheld for taxes			$ (2.2)	$ (15.6)
Number of brands | brands	25		25
Number of countries in which Edgewell operates | country	50		50
Accounting Standards Update 2016-09
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax provision			$ 0
Deferred tax assets	$ 9.7		$ 9.7

Acquisition (Details)

Acquisition (Details) - USD ($) $ in Millions	Mar. 01, 2018	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017
Business Acquisition [Line Items]
Acquisitions, net of cash acquired				$ 90.2	$ 34
Goodwill		$ 1,450.7		1,450.7		$ 1,445.9
Jack Black integration costs		2.3	$ 0	4.9	$ 0
Jack Black
Business Acquisition [Line Items]
Acquisition date	Mar. 1, 2018
Acquisitions, net of cash acquired	$ 90.2
Net assets		93.9		93.9
Working capital and other net assets		11.9		11.9
Cash acquired		3.7		3.7
Finite-lived intangible assets		47.7		47.7
Goodwill		$ 34.3		34.3
Weighted-average useful life of acquired finite-lived intangible assets		16 years 7 months 6 days
Selling, general and administrative expense | Jack Black
Business Acquisition [Line Items]
Jack Black integration costs		$ 0.5		$ 3.1
Cost of products sold | Jack Black
Business Acquisition [Line Items]
Jack Black integration costs		$ 1.8

Divestiture (Details)

Divestiture (Details) - USD ($) $ in Millions	Oct. 26, 2017	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Playtex gloves sale				$ 19	$ 0
Sale of Playtex gloves		$ (0.6)	$ 0	15.3	$ 0
Playtex gloves
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Playtex gloves sale				$ 19
Playtex gloves | Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Playtex gloves sale	$ 19
Value of sold assets	3.7
Sale of Playtex gloves	$ 15.3

Restructuring Charges (Narrativ

Restructuring Charges (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended				9 Months Ended				12 Months Ended
	Jun. 30, 2018		Jun. 30, 2017		Jun. 30, 2018		Jun. 30, 2017		Sep. 30, 2017
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 15.4		$ 12.5		$ 19.1		$ 24.9
Restructuring and related costs	15.9	[1]	12.8	[1]	19.6	[1]	25.6	[1]	$ 29.6
Project Fuel
Restructuring Cost and Reserve [Line Items]
Restructuring charges	15.9				19.6
2013 Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring charges			12.5				24.9
Restructuring charges incurred to date	170.1				170.1
IT enablement | Selling, general and administrative expense | Project Fuel
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 0.5				$ 0.5
Inventory obsolescence | Cost of products sold | 2013 Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs			$ 0.3				$ 0.7
[1]	Includes pre-tax Selling, general and administrative expense of $0.5 for the three and nine months ended June 30, 2018, associated with certain information technology enablement expenses related to Project Fuel. Includes pre-tax Cost of products sold of $0.3 and $0.7 for the three and nine months ended June 30, 2017, respectively, associated with obsolescence charges related to the exit of certain non-core product lines as a part of the 2013 Restructuring.

Restructuring Charges (Schedule

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Restructuring Cost and Reserve [Line Items]
Total Restructuring	$ 15.4	$ 12.5	$ 19.1	$ 24.9
2013 Restructuring
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		2.4		5.5
Asset impairment and accelerated depreciation		3.6		6.4
Consulting, project implementation and management and other exit costs		6.5		13
Total Restructuring		12.5		24.9
2013 Restructuring | Wet Shave
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0.4		1.1
Asset impairment and accelerated depreciation		0		0
Consulting, project implementation and management and other exit costs		2.9		6.8
Total Restructuring		3.3		7.9
2013 Restructuring | Sun and Skin Care
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0		0
Asset impairment and accelerated depreciation		0		0
Consulting, project implementation and management and other exit costs		0		0.1
Total Restructuring		0		0.1
2013 Restructuring | Feminine Care
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		2		4.4
Asset impairment and accelerated depreciation		3.6		6.4
Consulting, project implementation and management and other exit costs		3.6		6.1
Total Restructuring		$ 9.2		$ 16.9
Project Fuel
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs	2.9		5.2
Consulting, project implementation and management and other exit costs	13		14.4
Total Restructuring	15.9		19.6
Project Fuel | Wet Shave
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs	1.6		3.1
Consulting, project implementation and management and other exit costs	2		2
Total Restructuring	3.6		5.1
Project Fuel | Sun and Skin Care
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs	0.2		0.9
Consulting, project implementation and management and other exit costs	0.2		0.2
Total Restructuring	0.4		1.1
Project Fuel | Feminine Care
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs	1		1.1
Consulting, project implementation and management and other exit costs	0		0
Total Restructuring	1		1.1
Project Fuel | All Other
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs	0.1		0.1
Consulting, project implementation and management and other exit costs	0		0
Total Restructuring	0.1		0.1
Project Fuel | Corporate
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs	0		0
Consulting, project implementation and management and other exit costs	10.8		12.2
Total Restructuring	$ 10.8		$ 12.2

Restructuring Charges (Schedu39

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - USD ($) $ in Millions	3 Months Ended				9 Months Ended				12 Months Ended
	Jun. 30, 2018		Jun. 30, 2017	[1]	Jun. 30, 2018		Jun. 30, 2017		Sep. 30, 2017
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs	$ 15.9	[1]	$ 12.8		$ 19.6	[1]	$ 25.6	[1]	$ 29.6
Restructuring Reserve [Roll Forward]
Beginning Balance					2.4		16.7		16.7
Other					0				(0.3)
Utilized - Cash Payments					(11.9)				(36.7)
Utilized - Non-Cash					0				(6.9)
Ending Balance	10.1				10.1				2.4
Severance and termination related costs
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs					5.2				6.5
Restructuring Reserve [Roll Forward]
Beginning Balance					2.4		16.7		16.7
Other					0				(0.3)
Utilized - Cash Payments					(4.6)				(20.5)
Utilized - Non-Cash					0				0
Ending Balance	3				3				2.4
Asset impairment and accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs									6.9
Restructuring Reserve [Roll Forward]
Beginning Balance					0		0		0
Other									0
Utilized - Cash Payments									0
Utilized - Non-Cash									(6.9)
Ending Balance									0
Other related costs
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs					14.4				16.2
Restructuring Reserve [Roll Forward]
Beginning Balance					0		$ 0		0
Other					0				0
Utilized - Cash Payments					(7.3)				(16.2)
Utilized - Non-Cash					0				0
Ending Balance	$ 7.1				$ 7.1				$ 0
[1]	Includes pre-tax Selling, general and administrative expense of $0.5 for the three and nine months ended June 30, 2018, associated with certain information technology enablement expenses related to Project Fuel. Includes pre-tax Cost of products sold of $0.3 and $0.7 for the three and nine months ended June 30, 2017, respectively, associated with obsolescence charges related to the exit of certain non-core product lines as a part of the 2013 Restructuring.

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Tax Disclosure [Abstract]
Income tax provision	$ 9.3	$ 10.6	$ 56.4	$ 45.8
Earnings before income taxes	$ 21.4	$ 65.5	$ 140.3	$ 199.9
Effective tax rate	42.90%	16.20%	40.20%	22.90%
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Federal statutory income tax rate			35.00%
Newly enacted federal tax rate	21.00%		21.00%
Fiscal 2018 blended tax rate	24.50%		24.50%
Income tax provision	$ 9.3	$ 10.6	$ 56.4	$ 45.8
US Tax Act
Income Tax Disclosure [Abstract]
Income tax provision			17.4
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Transition tax, repatriation of foreign earnings, provision			94.2
Tax benefit, re-rate of DTAs for Tax Act			(76.8)
Income tax provision			$ 17.4

Earnings per Share (Schedule of

Earnings per Share (Schedule of Weighted-Average Shares Outstanding) (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Schedule Of Weighted Average Number Of Shares [Line Items]
Basic weighted-average shares outstanding (in shares)	54	57.2	54.5	57.4
Effect of dilutive securities (in shares)	0.1	0.3	0.1	0.3
Diluted weighted-average shares outstanding (in shares)	54.1	57.5	54.6	57.7
RSE awards
Schedule Of Weighted Average Number Of Shares [Line Items]
Effect of dilutive securities (in shares)	0.1	0.3	0.1	0.3

Earnings per Share (Narrative)

Earnings per Share (Narrative) (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Share options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.5	0.6	0.5	0.6
RSE awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.1		0.1

Goodwill and Intangible Asset43

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Goodwill [Roll Forward]
Beginning balance			$ 1,445.9
Acquisition of Jack Black			34.3
Cumulative translation adjustment			(5.1)
Impairment charge	$ 24.4	$ 0	24.4	$ 0
Ending balance	1,450.7		1,450.7
Wet Shave
Goodwill [Roll Forward]
Beginning balance			971.2
Acquisition of Jack Black			0
Cumulative translation adjustment			(2.6)
Impairment charge			0
Ending balance	968.6		968.6
Sun and Skin Care
Goodwill [Roll Forward]
Beginning balance			195.6
Acquisition of Jack Black			34.3
Cumulative translation adjustment			(0.3)
Impairment charge			0
Ending balance	229.6		229.6
Feminine Care
Goodwill [Roll Forward]
Beginning balance			209.5
Acquisition of Jack Black			0
Cumulative translation adjustment			(2.2)
Impairment charge			0
Ending balance	207.3		207.3
All Other
Goodwill [Line Items]
Goodwill, accumulated impairment loss	24.4		24.4
Goodwill [Roll Forward]
Beginning balance			69.6
Acquisition of Jack Black			0
Cumulative translation adjustment			0
Impairment charge	24.4
Ending balance	$ 45.2		$ 45.2

Goodwill and Intangible Asset44

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 465.4		$ 465.4		$ 418
Amortizable intangible assets, accumulated amortization	193.2		193.2		180.2
Amortizable intangible assets, net	272.2		272.2		237.8
Amortization of intangibles	4.6	$ 4	13.2	$ 12.1
Amortizable intangible assets, amortization expense, remainder of 2018	4.5		4.5
Amortizable intangible assets, amortization expense, fiscal 2019	17.8		17.8
Amortizable intangible assets, amortization expense, fiscal 2020	17.2		17.2
Amortizable intangible assets, amortization expense, fiscal 2021	16.6		16.6
Amortizable intangible assets, amortization expense, fiscal 2022	16.4		16.4
Amortizable intangible assets, amortization expense, fiscal 2023	16.4		16.4
Amortizable intangible assets, amortization expense, thereafter	183.5		183.5
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	206.7		206.7		188.6
Amortizable intangible assets, accumulated amortization	23		23		16
Amortizable intangible assets, net	183.7		183.7		172.6
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	79		79		77.9
Amortizable intangible assets, accumulated amortization	75.7		75.7		74.4
Amortizable intangible assets, net	3.3		3.3		3.5
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	179.7		179.7		151.5
Amortizable intangible assets, accumulated amortization	94.5		94.5		89.8
Amortizable intangible assets, net	85.2		85.2		$ 61.7
Skintimate brand name
Finite-Lived Intangible Assets [Line Items]
Useful life assigned to Skintimate brand name (in years)					20 years
Playtex brand name
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	$ 1.8		5.4
Jack Black | Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets acquired during period			17.5
Jack Black | Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets acquired during period			1.2
Jack Black | Noncompete agreements
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets acquired during period			0.5
Jack Black | Customer relationships
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets acquired during period			$ 28.5

Goodwill and Intangible Asset45

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017
Indefinite-lived Intangible Assets [Line Items]
Amortization of intangibles	$ 4.6	$ 4	$ 13.2	$ 12.1
Indefinite-lived intangible assets	832		832
Indefinite-lived intangible assets, decrease			(1.9)
Wet Shave
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	182.2		182.2
Sun and Skin Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 476.1		$ 476.1
Feminine Care
Indefinite-lived Intangible Assets [Line Items]
Reporting unit, fair value in excess of carry value	100.00%		100.00%
Goodwill, weighted average cost of capital	9.70%		9.70%
Valuation, long term growth rate	0.50%		0.50%
Indefinite-lived intangible assets	$ 29.9		$ 29.9
All Other
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 143.8		$ 143.8
Skin Care
Indefinite-lived Intangible Assets [Line Items]
Reporting unit, fair value in excess of carry value	100.00%		100.00%
Goodwill, weighted average cost of capital	10.20%		10.20%
Valuation, long term growth rate	2.00%		2.00%
Wet Ones brand name
Indefinite-lived Intangible Assets [Line Items]
Valuation, long term growth rate	1.30%		1.30%
Indefinite-lived intangible, fair value in excess of carry value	100.00%		100.00%
Valuation, discount rate	9.80%		9.80%
Playtex brand name
Indefinite-lived Intangible Assets [Line Items]
Impairment charge					$ 312
Edge brand
Indefinite-lived Intangible Assets [Line Items]
Impairment charge					$ 7
Playtex brand name
Indefinite-lived Intangible Assets [Line Items]
Amortization of intangibles	$ 1.8		$ 5.4

Supplemental Balance Sheet In46

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Jun. 30, 2018	Sep. 30, 2017
Inventories
Raw materials and supplies	$ 47	$ 50.6
Work in process	60.4	60.9
Finished products	234	222
Total inventories	341.4	333.5
Other Current Assets
Miscellaneous receivables	15.2	16.9
Prepaid expenses	77.4	55.6
Value added tax collectible from customers	26.9	25.2
Income taxes receivable	11	24.7
Other	4.8	3.3
Total other current assets	135.3	125.7
Property, Plant and Equipment
Land	19.2	19.3
Buildings	142.4	139.1
Machinery and equipment	960.6	947.4
Capitalized software costs	48.3	42.3
Construction in progress	51.7	49.7
Total gross property	1,222.2	1,197.8
Accumulated depreciation	(794.7)	(744.4)
Total property, plant and equipment, net	427.5	453.4
Other Current Liabilities
Accrued advertising, sales promotion and allowances	49.4	32.2
Accrued trade allowances	24.7	24.6
Accrued salaries, vacations and incentive compensation	46.6	40.6
Income taxes payable	24.2	18.3
Returns reserve	49.8	53.3
Restructuring reserve	10.1	3
Value added tax payable	7.8	5.8
Deferred compensation	4.7	13.8
Other	79.7	89.8
Total other current liabilities	297	281.4
Other Liabilities
Pensions and other retirement benefits	97.2	109.4
Deferred compensation	43	47.3
Long-term income taxes payable	36.1	0
Other non-current liabilities	58.2	58.8
Total other liabilities	$ 234.5	$ 215.5

Accounts Receivable Facility (D

Accounts Receivable Facility (Details) - Accounts receivable facility - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2018	Jun. 30, 2018	Sep. 30, 2017	Sep. 15, 2017
Transfer of Financial Assets Accounted for as Sales [Line Items]
Transfers of accounts receivable, max per agreement				$ 150
Transfer of accounts receivable, receivables sold	$ 328.5	$ 820.1
Transfer of accounts receivable, sales amount derecognized	136.9	136.9	$ 81.7
Transfer of accounts receivable, holdback from sale	13.7	13.7	$ 8.2
Loss on sale of accounts receivable	$ 0.8	$ 1.8

Debt (Details)

Debt (Details) - USD ($) $ in Millions		Jun. 30, 2018	Sep. 30, 2017
Debt Instrument [Line Items]
Total long-term debt, including current maturities		$ 1,281.4	$ 1,525.4
Current maturities of long-term debt		184.9	0
Long-term debt		1,096.5	1,525.4
Notes payable		20.9	19.4
Senior notes | Senior notes due 2021
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1]	598.6	598.3
Unamortized debt issuance costs		1.4	1.7
Senior notes | Senior notes due 2022
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1],[2]	497.9	497.4
Unamortized debt issuance costs		1.6	1.9
Unamortized discount		0.5	0.7
Domestic line of credit
Debt Instrument [Line Items]
Total long-term debt, including current maturities		0	245
Loans payable
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1]	184.9	184.7
Unamortized debt issuance costs		$ 0.1	$ 0.3
[1]	At June 30, 2018, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.4, $1.6 and $0.1, respectively. At September 30, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.7, $1.9 and $0.3, respectively.
[2]	At June 30, 2018 and September 30, 2017, the balance for the senior notes due 2022 is reflected net of discounts of $0.5 and $0.7, respectively.

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Retirement Benefits [Abstract]
Service cost	$ 1.5	$ 1.8	$ 4.6	$ 5.5
Interest cost	4.3	3.7	12.9	11.2
Expected return on plan assets	(7.9)	(7.9)	(23.8)	(23.8)
Recognized net actuarial loss	1.1	1.6	3.4	4.6
Settlement loss recognized	0	0	0	0.3
Net periodic benefit (credit) cost	$ (1)	$ (0.8)	$ (2.9)	$ (2.2)

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($) shares in Millions, $ in Millions	9 Months Ended
	Jun. 30, 2018	Jan. 26, 2018
Stockholders' Equity Note [Abstract]
Shares authorized for repurchase (in shares)		10
Repurchase of shares (in shares)	2.1
Repurchase of shares (in usd)	$ 124.4
Remaining shares authorized for repurchase (in shares)	10
Cash dividends paid related to RSE award vests	$ 0.1

Accumulated Other Comprehensi51

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		9 Months Ended
		Jun. 30, 2018	Jun. 30, 2017
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ (131.4)	$ (197.2)
OCI before reclassifications	[1]	(9)	19.3
Reclassifications to earnings		4.1	1.6
Ending balance		(136.3)	(176.3)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(29)	(68.1)
OCI before reclassifications	[1]	(10.4)	15.1
Reclassifications to earnings		0	0
Ending balance		(39.4)	(53)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(101.3)	(126.3)
OCI before reclassifications	[1]	0.2	(0.1)
Reclassifications to earnings		2.4	3.2
Ending balance		(98.7)	(123.2)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(1.1)	(2.8)
OCI before reclassifications	[1]	1.2	4.3
Reclassifications to earnings		1.7	(1.6)
Ending balance		$ 1.8	$ (0.1)
[1]	OCI is defined as other comprehensive income (loss).

Accumulated Other Comprehensi52

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassifications to earnings				$ (4.1)	$ (1.6)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		$ (1)	$ 1.1	(2.5)	2.5
Gains and losses on cash flow hedges, foreign exchange contracts, tax		0.4	(0.4)	0.8	(0.9)
Gains and losses on cash flow hedges, foreign exchange contracts, after tax		(0.6)	0.7	(1.7)	1.6
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	[1]	(1.1)	(1.6)	(3.4)	(4.6)
Settlement loss recognized, before tax	[1]	0	0	0	(0.3)
Amortization of defined benefit pension and postretirement items, before tax		(1.1)	(1.6)	(3.4)	(4.9)
Amortization of defined benefit pension and postretirement items, tax		0.3	0.6	1	1.7
Amortization of defined benefit pension and postretirement items, after tax		(0.8)	(1)	(2.4)	(3.2)
Reclassifications to earnings		(1.4)	(0.3)	(4.1)	(1.6)
Other expense (income), net | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		$ (1)	$ 1.1	$ (2.5)	$ 2.5
[1]	These AOCI components are included in the computation of net periodic benefit cost. See Note 11 of Notes to Condensed Consolidated Financial Statements

Financial Instruments and Ris53

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2018USD ($)contracts	Jun. 30, 2017USD ($)	Jun. 30, 2018USD ($)contracts	Jun. 30, 2017USD ($)	Sep. 30, 2017USD ($)
Derivative [Line Items]
Long-term debt		$ 1,281.4		$ 1,281.4		$ 1,525.4
Fixed rate
Derivative [Line Items]
Long-term debt		1,096.5		1,096.5		1,095.7
Fair value of long-term debt		1,059.5		1,059.5		1,143.8
Loans payable
Derivative [Line Items]
Long-term debt	[1]	184.9		184.9		184.7
Fair value of long-term debt		$ 185		$ 185		185
Not designated as hedge | FX contract
Derivative [Line Items]
Open foreign currency contracts | contracts		4		4
Notional value		$ 48		$ 48
Cash flow hedge | Designated as hedge | FX contract
Derivative [Line Items]
Estimated fair value of derivative		$ 2.6		$ 2.6		$ (1.6)
Open foreign currency contracts | contracts		64		64
Notional value		$ 137.8		$ 137.8
Other expense (income), net | Not designated as hedge | FX contract
Derivative [Line Items]
Change in estimate fair value of foreign currency contracts	[2]	$ 3	$ 1.6	$ 0.2	$ 2
[1]	At June 30, 2018, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.4, $1.6 and $0.1, respectively. At September 30, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.7, $1.9 and $0.3, respectively.
[2]	Gain (loss) was recorded in Other expense (income), net.

Financial Instruments and Ris54

Financial Instruments and Risk Management (Schedule of Fair Values of Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		Jun. 30, 2018	Sep. 30, 2017
Not designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 1.1	$ 0.4
Cash flow hedge | Designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 2.6	$ (1.6)
[1]	All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris55

Financial Instruments and Risk Management (Schedule of Gains and Losses on Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	[1]	$ 5.4	$ (1.5)	$ 1.7	$ 6.7
Other expense (income), net | Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from AOCI into income (effective portion)	[1],[2]	(1)	1.1	(2.5)	2.5
Other expense (income), net | Not designated as hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	[2]	$ 3	$ 1.6	$ 0.2	$ 2
[1]	Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.
[2]	Gain (loss) was recorded in Other expense (income), net.

Financial Instruments and Ris56

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions		Jun. 30, 2018	Sep. 30, 2017
Derivative [Line Items]
Gross amounts of recognized assets	[1]	$ 4	$ 2.5
Gross amounts of recognized liabilities	[2]	0	(3.7)
Gross amounts offset in the balance sheet	[1]	(0.3)	(0.1)
Gross amounts offset in the balance sheet	[2]	0	0.1
Net amounts of assets presented in the balance sheet	[1]	3.7	2.4
Net amounts of liabilities presented in the balance sheet	[2]	$ 0	$ (3.6)
[1]	All derivative assets are presented in Other current assets or Other assets.
[2]	All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris57

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Jun. 30, 2018	Sep. 30, 2017
Derivative [Line Items]
Deferred compensation	$ (47.6)	$ (60.9)
Net liabilities at estimated fair value	(43.9)	(62.1)
FX contract
Derivative [Line Items]
Derivatives - foreign currency contracts	$ 3.7	$ (1.2)

Segment Data (Schedule of Segme

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($) $ in Millions	3 Months Ended				9 Months Ended				12 Months Ended
	Jun. 30, 2018		Jun. 30, 2017		Jun. 30, 2018		Jun. 30, 2017		Sep. 30, 2017
Segment Reporting Information [Line Items]
Restructuring charges	$ 15.4		$ 12.5		$ 19.1		$ 24.9
Net sales	620.6		637.5		1,697		1,733.5
Segment profit	106.7		116.5		300.6		337.9
General corporate and other expenses	(17.5)		(18.2)		(54.7)		(58.1)
Impairment charge	(24.4)		0		(24.4)		0
Restructuring and related costs	(15.9)	[1]	(12.8)	[1]	(19.6)	[1]	(25.6)	[1]	$ (29.6)
Jack Black integration costs	(2.3)		0		(4.9)		0
Sale of Playtex gloves	(0.6)		0		15.3		0
Amortization of intangibles	(4.6)		(4)		(13.2)		(12.1)
Interest and other expense, net	(20)		(16)		(58.8)		(42.2)
Earnings before income taxes	21.4		65.5		140.3		199.9
Wet Shave
Segment Reporting Information [Line Items]
Net sales	341.1		358.5		980.4		1,007.3
Segment profit	56		59.8		180.5		205
Impairment charge					0
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales	162.8		161.1		374.2		369.3
Segment profit	34.1		42.4		76.9		94.1
Impairment charge					0
Feminine Care
Segment Reporting Information [Line Items]
Net sales	84.1		86.4		247		258.7
Segment profit	11.1		7.6		26.2		17.5
Impairment charge					0
All Other
Segment Reporting Information [Line Items]
Net sales	32.6		31.5		95.4		98.2
Segment profit	5.5		6.7		17		21.3
Impairment charge	(24.4)
Project Fuel
Segment Reporting Information [Line Items]
Restructuring charges	15.9				19.6
Project Fuel | Wet Shave
Segment Reporting Information [Line Items]
Restructuring charges	3.6				5.1
Project Fuel | Sun and Skin Care
Segment Reporting Information [Line Items]
Restructuring charges	0.4				1.1
Project Fuel | Feminine Care
Segment Reporting Information [Line Items]
Restructuring charges	1				1.1
Project Fuel | All Other
Segment Reporting Information [Line Items]
Restructuring charges	0.1				0.1
2013 Restructuring
Segment Reporting Information [Line Items]
Restructuring charges			12.5				24.9
2013 Restructuring | Wet Shave
Segment Reporting Information [Line Items]
Restructuring charges			3.3				7.9
2013 Restructuring | Sun and Skin Care
Segment Reporting Information [Line Items]
Restructuring charges			0				0.1
2013 Restructuring | Feminine Care
Segment Reporting Information [Line Items]
Restructuring charges			9.2				16.9
IT enablement | Project Fuel | Selling, general and administrative expense
Segment Reporting Information [Line Items]
Restructuring charges	$ 0.5				$ 0.5
Inventory obsolescence | 2013 Restructuring | Cost of products sold
Segment Reporting Information [Line Items]
Restructuring and related costs			$ (0.3)				$ (0.7)
[1]	Includes pre-tax Selling, general and administrative expense of $0.5 for the three and nine months ended June 30, 2018, associated with certain information technology enablement expenses related to Project Fuel. Includes pre-tax Cost of products sold of $0.3 and $0.7 for the three and nine months ended June 30, 2017, respectively, associated with obsolescence charges related to the exit of certain non-core product lines as a part of the 2013 Restructuring.

Segment Data (Schedule of Suppl

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenue from External Customer [Line Items]
Net sales	$ 620.6	$ 637.5	$ 1,697	$ 1,733.5
Razors and blades
Revenue from External Customer [Line Items]
Net sales	304.6	319.3	877.5	896.2
Sun care products
Revenue from External Customer [Line Items]
Net sales	132.1	136.9	297.5	305.8
Tampons, Pads and Liners [Member]
Revenue from External Customer [Line Items]
Net sales	84.1	86.4	247	258.7
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	36.5	39.2	102.9	111.1
Infant care and other
Revenue from External Customer [Line Items]
Net sales	32.6	31.5	95.4	98.2
Skin care products
Revenue from External Customer [Line Items]
Net sales	$ 30.7	$ 24.2	$ 76.7	$ 63.5

Guarantor and Non-Guarantor F60

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Net sales	$ 620.6	$ 637.5	$ 1,697	$ 1,733.5
Cost of products sold	317.9	315.4	891.9	873.8
Gross profit	302.7	322.1	805.1	859.7
Selling, general and administrative expense	100.7	97.5	301.4	295.2
Advertising and sales promotion expense	105.3	114.2	229.9	247.3
Research and development expense	14.9	16.4	46.5	50.2
Impairment charge	24.4	0	24.4	0
Restructuring charges	15.4	12.5	19.1	24.9
Sale of Playtex gloves	0.6	0	(15.3)	0
Interest expense associated with debt	16.5	17.6	52.5	52.3
Other expense (income), net	3.5	(1.6)	6.3	(10.1)
Intercompany service fees	0	0	0	0
Equity in earnings of subsidiaries	0	0	0	0
Earnings before income taxes	21.4	65.5	140.3	199.9
Income tax (benefit) provision	9.3	10.6	56.4	45.8
Net earnings	12.1	54.9	83.9	154.1
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	12.1	54.9	83.9	154.1
Other comprehensive income, net of tax	(30)	40.6	(4.9)	20.9
Total comprehensive income	(17.9)	95.5	79	175
Eliminations
Income Statement [Abstract]
Net sales	(82.5)	(101.7)	(235.4)	(289.9)
Cost of products sold	(82.5)	(101.7)	(235.4)	(289.9)
Gross profit	0	0	0	0
Selling, general and administrative expense	0	0	0	0
Advertising and sales promotion expense	0	0	0	0
Research and development expense	0	0	0	0
Impairment charge	0		0
Restructuring charges	0	0	0	0
Sale of Playtex gloves	0		0
Interest expense associated with debt	0	0	0	0
Other expense (income), net	0	0	0	0
Intercompany service fees	0	0	0	0
Equity in earnings of subsidiaries	47.6	95.6	192.3	269
Earnings before income taxes	(47.6)	(95.6)	(192.3)	(269)
Income tax (benefit) provision	0	0	0	0
Net earnings	(47.6)	(95.6)	(192.3)	(269)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	(47.6)	(95.6)	(192.3)	(269)
Other comprehensive income, net of tax	60.5	(80.8)	11.4	(40)
Total comprehensive income	12.9	(176.4)	(180.9)	(309)
Parent
Income Statement [Abstract]
Net sales	0	0	0	0
Cost of products sold	0	0	0	0
Gross profit	0	0	0	0
Selling, general and administrative expense	0	0	0	0
Advertising and sales promotion expense	0	0	0	0
Research and development expense	0	0	0	0
Impairment charge	0		0
Restructuring charges	0	0	0	0
Sale of Playtex gloves	0		0
Interest expense associated with debt	13.4	13.4	40.1	40.1
Other expense (income), net	0	0	0	0
Intercompany service fees	0	0	0	0
Equity in earnings of subsidiaries	(21.9)	(64.1)	(113.2)	(180.1)
Earnings before income taxes	8.5	50.7	73.1	140
Income tax (benefit) provision	(3.6)	(4.2)	(10.8)	(14.1)
Net earnings	12.1	54.9	83.9	154.1
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	12.1	54.9	83.9	154.1
Other comprehensive income, net of tax	(30)	40.6	(4.9)	20.9
Total comprehensive income	(17.9)	95.5	79	175
Guarantors
Income Statement [Abstract]
Net sales	425.1	447.8	1,143.9	1,224.1
Cost of products sold	236.9	247.6	661.9	689.1
Gross profit	188.2	200.2	482	535
Selling, general and administrative expense	61.2	63.6	187.9	192.2
Advertising and sales promotion expense	70	76.9	139.3	159.8
Research and development expense	14.9	16.3	46.5	49.6
Impairment charge	24.4		24.4
Restructuring charges	13.4	2.5	15.8	7.4
Sale of Playtex gloves	0.6		(15.3)
Interest expense associated with debt	2.8	4	11.6	11.1
Other expense (income), net	0.8	0	1.8	0
Intercompany service fees	(3.5)	(4.7)	(14.6)	(17.2)
Equity in earnings of subsidiaries	(25.7)	(31.5)	(79.1)	(88.9)
Earnings before income taxes	29.3	73.1	163.7	221
Income tax (benefit) provision	7.4	9	50.5	40.9
Net earnings	21.9	64.1	113.2	180.1
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	21.9	64.1	113.2	180.1
Other comprehensive income, net of tax	(30)	40.6	(4.9)	20.9
Total comprehensive income	(8.1)	104.7	108.3	201
Non-Guarantors
Income Statement [Abstract]
Net sales	278	291.4	788.5	799.3
Cost of products sold	163.5	169.5	465.4	474.6
Gross profit	114.5	121.9	323.1	324.7
Selling, general and administrative expense	39.5	33.9	113.5	103
Advertising and sales promotion expense	35.3	37.3	90.6	87.5
Research and development expense	0	0.1	0	0.6
Impairment charge	0		0
Restructuring charges	2	10	3.3	17.5
Sale of Playtex gloves	0		0
Interest expense associated with debt	0.3	0.2	0.8	1.1
Other expense (income), net	2.7	(1.6)	4.5	(10.1)
Intercompany service fees	3.5	4.7	14.6	17.2
Equity in earnings of subsidiaries	0	0	0	0
Earnings before income taxes	31.2	37.3	95.8	107.9
Income tax (benefit) provision	5.5	5.8	16.7	19
Net earnings	25.7	31.5	79.1	88.9
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	25.7	31.5	79.1	88.9
Other comprehensive income, net of tax	(30.5)	40.2	(6.5)	19.1
Total comprehensive income	$ (4.8)	$ 71.7	$ 72.6	$ 108

Guarantor and Non-Guarantor F61

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Balance Sheets) (Details) - USD ($) $ in Millions	Jun. 30, 2018		Sep. 30, 2017		Jun. 30, 2017	Sep. 30, 2016
Current assets
Cash and cash equivalents	$ 218.5		$ 502.9		$ 454.9	$ 738.9
Trade receivables, net	225.6		224.1
Inventories	341.4		333.5
Other current assets	135.3		125.7
Total current assets	920.8		1,186.2
Investment in subsidiaries	0		0
Intercompany receivables, net	0	[1]	0	[2]
Property, plant and equipment, net	427.5		453.4
Goodwill	1,450.7		1,445.9
Other intangible assets, net	1,104.2		1,071.7
Other assets	33.4		31.6
Total assets	3,936.6		4,188.8
Liabilities [Abstract]
Current liabilities	736.7		524.4
Intercompany payables, net	0	[1]	0	[2]
Long-term debt	1,096.5		1,525.4
Deferred income tax liabilities	151		181.8
Other liabilities	234.5		215.5
Total liabilities	2,218.7		2,447.1
Shareholders' equity
Total shareholders' equity	1,717.9		1,741.7
Total liabilities and shareholders' equity	3,936.6		4,188.8
Eliminations
Current assets
Cash and cash equivalents	0		0		0	0
Trade receivables, net	0		0
Inventories	0		0
Other current assets	0		0
Total current assets	0		0
Investment in subsidiaries	(4,905)		(4,917.3)
Intercompany receivables, net	(905.8)	[1]	(698.9)	[2]
Property, plant and equipment, net	0		0
Goodwill	0		0
Other intangible assets, net	0		0
Other assets	0		0
Total assets	(5,810.8)		(5,616.2)
Liabilities [Abstract]
Current liabilities	0		0
Intercompany payables, net	(905.8)	[1]	(698.9)	[2]
Long-term debt	0		0
Deferred income tax liabilities	0		0
Other liabilities	0		0
Total liabilities	(905.8)		(698.9)
Shareholders' equity
Total shareholders' equity	(4,905)		(4,917.3)
Total liabilities and shareholders' equity	(5,810.8)		(5,616.2)
Parent
Current assets
Cash and cash equivalents	0		0		0	0
Trade receivables, net	0		0
Inventories	0		0
Other current assets	0		0
Total current assets	0		0
Investment in subsidiaries	3,725.5		3,554.1
Intercompany receivables, net	0	[1]	0	[2]
Property, plant and equipment, net	0		0
Goodwill	0		0
Other intangible assets, net	0		0
Other assets	1.1		1.6
Total assets	3,726.6		3,555.7
Liabilities [Abstract]
Current liabilities	6.4		19.3
Intercompany payables, net	905.8	[1]	698.9	[2]
Long-term debt	1,096.5		1,095.4
Deferred income tax liabilities	0		0
Other liabilities	0		0.4
Total liabilities	2,008.7		1,814
Shareholders' equity
Total shareholders' equity	1,717.9		1,741.7
Total liabilities and shareholders' equity	3,726.6		3,555.7
Guarantors
Current assets
Cash and cash equivalents	5.6		6.4		19.7	5.8
Trade receivables, net	46.5		34.4
Inventories	191.3		198.7
Other current assets	49.6		46.3
Total current assets	293		285.8
Investment in subsidiaries	1,179.5		1,363.2
Intercompany receivables, net	849	[1]	644.2	[2]
Property, plant and equipment, net	319.2		335.7
Goodwill	1,037.5		1,061.9
Other intangible assets, net	889.8		900.3
Other assets	0.1		0.1
Total assets	4,568.1		4,591.2
Liabilities [Abstract]
Current liabilities	506.3		259.8
Intercompany payables, net	0	[1]	0	[2]
Long-term debt	0		430
Deferred income tax liabilities	115.9		147.6
Other liabilities	220.4		199.7
Total liabilities	842.6		1,037.1
Shareholders' equity
Total shareholders' equity	3,725.5		3,554.1
Total liabilities and shareholders' equity	4,568.1		4,591.2
Non-Guarantors
Current assets
Cash and cash equivalents	212.9		496.5		$ 435.2	$ 733.1
Trade receivables, net	179.1		189.7
Inventories	150.1		134.8
Other current assets	85.7		79.4
Total current assets	627.8		900.4
Investment in subsidiaries	0		0
Intercompany receivables, net	56.8	[1]	54.7	[2]
Property, plant and equipment, net	108.3		117.7
Goodwill	413.2		384
Other intangible assets, net	214.4		171.4
Other assets	32.2		29.9
Total assets	1,452.7		1,658.1
Liabilities [Abstract]
Current liabilities	224		245.3
Intercompany payables, net	0	[1]	0	[2]
Long-term debt	0		0
Deferred income tax liabilities	35.1		34.2
Other liabilities	14.1		15.4
Total liabilities	273.2		294.9
Shareholders' equity
Total shareholders' equity	1,179.5		1,363.2
Total liabilities and shareholders' equity	$ 1,452.7		$ 1,658.1
[1]	Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.
[2]	Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

Guarantor and Non-Guarantor F62

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Cash Flows) (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash Flow from Operating Activities
Net cash flow from operations	$ 193.3	$ 135
Cash Flow from Investing Activities
Capital expenditures	(41.8)	(45.4)
Acquisitions, net of cash acquired	(90.2)	(34)
Playtex gloves sale	19	0
Proceeds from sale of assets	4.7	5.9
Net cash used by investing activities	(108.3)	(73.5)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	477	181
Cash payments on debt with original maturities greater than 90 days	(722)	(423)
Net (decrease) increase in debt with original maturities of 90 days or less	0.2	0.1
Common shares purchased	(124.4)	(94.6)
Intercompany dividend	0	0
Employee shares withheld for taxes	(2.2)	(15.6)
Excess tax benefits from share-based payments	0	1.9
Net cash (used by) from financing activities	(371.4)	(350.2)
Effect of exchange rate changes on cash	2	4.7
Net increase (decrease) in cash and cash equivalents	(284.4)	(284)
Cash and cash equivalents, beginning of period	502.9	738.9
Cash and cash equivalents, end of period	218.5	454.9
Eliminations
Cash Flow from Operating Activities
Net cash flow from operations	(350.2)	(70)
Cash Flow from Investing Activities
Capital expenditures	0	0
Acquisitions, net of cash acquired	0	0
Proceeds from sale of assets	0	0
Net cash used by investing activities	0	0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Net (decrease) increase in debt with original maturities of 90 days or less	0	0
Common shares purchased	0	0
Intercompany dividend	350.2	70
Employee shares withheld for taxes	0	0
Excess tax benefits from share-based payments		0
Net cash (used by) from financing activities	350.2	70
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Parent
Cash Flow from Operating Activities
Net cash flow from operations	126.6	108.3
Cash Flow from Investing Activities
Capital expenditures	0	0
Acquisitions, net of cash acquired	0	0
Proceeds from sale of assets	0	0
Net cash used by investing activities	0	0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Net (decrease) increase in debt with original maturities of 90 days or less	0	0
Common shares purchased	(124.4)	(94.6)
Intercompany dividend	0	0
Employee shares withheld for taxes	(2.2)	(15.6)
Excess tax benefits from share-based payments		1.9
Net cash (used by) from financing activities	(126.6)	(108.3)
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Guarantors
Cash Flow from Operating Activities
Net cash flow from operations	343.2	8.3
Cash Flow from Investing Activities
Capital expenditures	(31.3)	(36)
Acquisitions, net of cash acquired	(90.2)	0
Proceeds from sale of assets	4.7	5.9
Net cash used by investing activities	(97.8)	(30.1)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	477	181
Cash payments on debt with original maturities greater than 90 days	(722)	(146)
Net (decrease) increase in debt with original maturities of 90 days or less	(1.2)	0.7
Common shares purchased	0	0
Intercompany dividend	0	0
Employee shares withheld for taxes	0	0
Excess tax benefits from share-based payments		0
Net cash (used by) from financing activities	(246.2)	35.7
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash and cash equivalents	(0.8)	13.9
Cash and cash equivalents, beginning of period	6.4	5.8
Cash and cash equivalents, end of period	5.6	19.7
Non-Guarantors
Cash Flow from Operating Activities
Net cash flow from operations	73.7	88.4
Cash Flow from Investing Activities
Capital expenditures	(10.5)	(9.4)
Acquisitions, net of cash acquired	0	(34)
Proceeds from sale of assets	0	0
Net cash used by investing activities	(10.5)	(43.4)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	(277)
Net (decrease) increase in debt with original maturities of 90 days or less	1.4	(0.6)
Common shares purchased	0	0
Intercompany dividend	(350.2)	(70)
Employee shares withheld for taxes	0	0
Excess tax benefits from share-based payments		0
Net cash (used by) from financing activities	(348.8)	(347.6)
Effect of exchange rate changes on cash	2	4.7
Net increase (decrease) in cash and cash equivalents	(283.6)	(297.9)
Cash and cash equivalents, beginning of period	496.5	733.1
Cash and cash equivalents, end of period	212.9	$ 435.2
Playtex gloves
Cash Flow from Investing Activities
Playtex gloves sale	19
Playtex gloves | Eliminations
Cash Flow from Investing Activities
Playtex gloves sale	0
Playtex gloves | Parent
Cash Flow from Investing Activities
Playtex gloves sale	0
Playtex gloves | Guarantors
Cash Flow from Investing Activities
Playtex gloves sale	19
Playtex gloves | Non-Guarantors
Cash Flow from Investing Activities
Playtex gloves sale	$ 0